,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1107750,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,4621,MYH3,https://ctdbase.org/detail.go?type=gene&acc=4621,,,4621.0,MYH3,10116.0,Rattus norvegicus (Norway rat),Dioxins affects the methylation of MYH3 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
1,1107751,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,10116.0,Rattus norvegicus (Norway rat),Dioxins affects the methylation of MYH7 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
2,1292876,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,284001,CCDC57,https://ctdbase.org/detail.go?type=gene&acc=284001,,,284001.0,CCDC57,239089.0,Homo sapiens (human),Cupric chloride results in decreased expression of CCDC57 protein,,,PMID:22699969,https://www.ncbi.nlm.nih.gov/pubmed/22699969,22699969,,
3,1292877,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606.0,Homo sapiens (human),Cupric chloride results in increased expression of CCN1 mRNA,,,PMID:17211630,https://www.ncbi.nlm.nih.gov/pubmed/17211630,17211630,,
4,1292878,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,9973,CCS,https://ctdbase.org/detail.go?type=gene&acc=9973,,,9973.0,CCS,9606.0,Homo sapiens (human),Cupric chloride results in increased degradation of and results in decreased expression of CCS protein,,,PMID:16531609,https://www.ncbi.nlm.nih.gov/pubmed/16531609,16531609,,
5,1293010,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Cupric chloride affects the expression of CDKN1A mRNA,,,PMID:17211630,https://www.ncbi.nlm.nih.gov/pubmed/17211630,17211630,,
6,1293011,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,10090.0,Mus musculus (house mouse),Cupric chloride affects the expression of CDKN1B protein,,,PMID:23313662,https://www.ncbi.nlm.nih.gov/pubmed/23313662,23313662,,
7,1293012,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1033,CDKN3,https://ctdbase.org/detail.go?type=gene&acc=1033,,,1033.0,CDKN3,7955.0,Danio rerio (zebrafish),Cupric chloride results in decreased expression of CDKN3 mRNA,,,PMID:19174923,https://www.ncbi.nlm.nih.gov/pubmed/19174923,19174923,,
8,1293013,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,8128.0,Oreochromis niloticus (Nile tilapia),Cupric chloride results in increased expression of CEBPB protein,,,PMID:19616320,https://www.ncbi.nlm.nih.gov/pubmed/19616320,19616320,,
9,1293014,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1056,CEL,https://ctdbase.org/detail.go?type=gene&acc=1056,,,1056.0,CEL,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of CEL mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
10,1293015,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,322481,CEL.1,https://ctdbase.org/detail.go?type=gene&acc=322481,,,322481.0,cel.1,7955.0,Danio rerio (zebrafish),Cupric chloride results in decreased expression of CEL.1 mRNA,,,PMID:19174923,https://www.ncbi.nlm.nih.gov/pubmed/19174923,19174923,,
11,1293016,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,565117,CEL.2,https://ctdbase.org/detail.go?type=gene&acc=565117,,,565117.0,cel.2,7955.0,Danio rerio (zebrafish),Cupric chloride results in decreased expression of CEL.2 mRNA,,,PMID:19174923,https://www.ncbi.nlm.nih.gov/pubmed/19174923,19174923,,
12,1293017,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,22995,CEP152,https://ctdbase.org/detail.go?type=gene&acc=22995,,,22995.0,CEP152,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of CEP152 mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
13,1291608,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,184366,COL-73,https://ctdbase.org/detail.go?type=gene&acc=184366,,,184366.0,col-73,6239.0,Caenorhabditis elegans,Mercuric chloride results in decreased expression of COL-73 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
14,1292232,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,175938,CTSA-4.2,https://ctdbase.org/detail.go?type=gene&acc=175938,,,175938.0,ctsa-4.2,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of CTSA-4.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
15,1292233,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10090.0,Mus musculus (house mouse),Mercuric chloride results in increased activity of CTSB protein,,,PMID:25237059,https://www.ncbi.nlm.nih.gov/pubmed/25237059,25237059,,
16,1292234,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,406645,CTSBA,https://ctdbase.org/detail.go?type=gene&acc=406645,,,406645.0,ctsba,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of CTSBA mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
17,1292696,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Mercuric chloride results in decreased expression of CYP1A2 protein,,,PMID:37172713,https://www.ncbi.nlm.nih.gov/pubmed/37172713,37172713,,
18,1292697,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Mercuric chloride results in increased expression of CYP1B1 mRNA,,,PMID:21435368|PMID:24472606,https://www.ncbi.nlm.nih.gov/pubmed/21435368|https://www.ncbi.nlm.nih.gov/pubmed/24472606,21435368|24472606,,
19,1292698,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of CYP1C1 mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
20,1292699,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,181926,CYP-29A4,https://ctdbase.org/detail.go?type=gene&acc=181926,,,181926.0,cyp-29A4,6239.0,Caenorhabditis elegans,Mercuric chloride results in decreased expression of CYP-29A4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
21,1292700,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),Mercuric chloride results in increased expression of CYP2B10 mRNA,,,PMID:24472606,https://www.ncbi.nlm.nih.gov/pubmed/24472606,24472606,,
22,1292701,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,13090,CYP2B19,https://ctdbase.org/detail.go?type=gene&acc=13090,,,13090.0,Cyp2b19,10090.0,Mus musculus (house mouse),Mercuric chloride results in increased expression of CYP2B19 mRNA,,,PMID:24472606,https://www.ncbi.nlm.nih.gov/pubmed/24472606,24472606,,
23,1178087,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082.0,SSPN,9606.0,Homo sapiens (human),[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SSPN mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
24,1178088,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cadmium chloride results in increased expression of SSR1 mRNA,,,PMID:23741332,https://www.ncbi.nlm.nih.gov/pubmed/23741332,23741332,,
25,1178089,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,10116.0,Rattus norvegicus (Norway rat),Cadmium chloride results in decreased methylation of SSR1 promoter,,,PMID:22457795,https://www.ncbi.nlm.nih.gov/pubmed/22457795,22457795,,
26,1291772,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,5687,PSMA6,https://ctdbase.org/detail.go?type=gene&acc=5687,,,5687.0,PSMA6,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of PSMA6 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
27,1291773,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,5688,PSMA7,https://ctdbase.org/detail.go?type=gene&acc=5688,,,5688.0,PSMA7,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of PSMA7 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
28,1292080,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Tetradecanoylphorbol acetate results in increased activity of JUN protein,,,PMID:8777434,https://www.ncbi.nlm.nih.gov/pubmed/8777434,8777434,,
29,1292081,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6134,RPL10,https://ctdbase.org/detail.go?type=gene&acc=6134,,,6134.0,RPL10,9606.0,Homo sapiens (human),Chromium hexavalent ion affects the expression of RPL10 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
30,1292082,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6134,RPL10,https://ctdbase.org/detail.go?type=gene&acc=6134,,,6134.0,RPL10,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL10 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
31,1292083,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,4736,RPL10A,https://ctdbase.org/detail.go?type=gene&acc=4736,,,4736.0,RPL10A,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL10A mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
32,1292084,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6135,RPL11,https://ctdbase.org/detail.go?type=gene&acc=6135,,,6135.0,RPL11,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL11 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
33,1292085,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6137,RPL13,https://ctdbase.org/detail.go?type=gene&acc=6137,,,6137.0,RPL13,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL13 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
34,1292086,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,23521,RPL13A,https://ctdbase.org/detail.go?type=gene&acc=23521,,,23521.0,RPL13A,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL13A mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
35,1292087,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,9045,RPL14,https://ctdbase.org/detail.go?type=gene&acc=9045,,,9045.0,RPL14,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL14 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
36,1292088,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6138,RPL15,https://ctdbase.org/detail.go?type=gene&acc=6138,,,6138.0,RPL15,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of RPL15 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
37,1291934,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,286133,SCARA5,https://ctdbase.org/detail.go?type=gene&acc=286133,,,286133.0,SCARA5,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SCARA5 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
38,1291935,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SCD mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
39,1291936,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SCD1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
40,1291937,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6328,SCN3A,https://ctdbase.org/detail.go?type=gene&acc=6328,,,6328.0,SCN3A,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SCN3A mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
41,1291938,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,55800,SCN3B,https://ctdbase.org/detail.go?type=gene&acc=55800,,,55800.0,SCN3B,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SCN3B mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
42,1291939,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,642658,SCX,https://ctdbase.org/detail.go?type=gene&acc=642658,,,642658.0,SCX,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SCX mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
43,1291940,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,27111,SDCBP2,https://ctdbase.org/detail.go?type=gene&acc=27111,,,27111.0,SDCBP2,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SDCBP2 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
44,1291941,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,8991,SELENBP1,https://ctdbase.org/detail.go?type=gene&acc=8991,,,8991.0,SELENBP1,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SELENBP1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
45,1292531,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,11000,SLC27A3,https://ctdbase.org/detail.go?type=gene&acc=11000,,,11000.0,SLC27A3,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLC27A3 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
46,1292532,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SLC2A1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
47,1292533,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,55089,SLC38A4,https://ctdbase.org/detail.go?type=gene&acc=55089,,,55089.0,SLC38A4,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SLC38A4 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
48,1292534,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,92745,SLC38A5,https://ctdbase.org/detail.go?type=gene&acc=92745,,,92745.0,SLC38A5,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLC38A5 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
49,1292535,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,64116,SLC39A8,https://ctdbase.org/detail.go?type=gene&acc=64116,,,64116.0,SLC39A8,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLC39A8 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
50,1292536,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,30061,SLC40A1,https://ctdbase.org/detail.go?type=gene&acc=30061,,,30061.0,SLC40A1,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SLC40A1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
51,1292537,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,29015,SLC43A3,https://ctdbase.org/detail.go?type=gene&acc=29015,,,29015.0,SLC43A3,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SLC43A3 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
52,1292871,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of SOX2 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
53,1292872,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SOX4 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
54,1292873,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SP1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
55,1292874,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6672,SP100,https://ctdbase.org/detail.go?type=gene&acc=6672,,,6672.0,SP100,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SP100 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
56,1292875,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,389058,SP5,https://ctdbase.org/detail.go?type=gene&acc=389058,,,389058.0,SP5,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SP5 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
57,1291942,31401,Drug Gene Interaction database (DGIdb),Ursodiol,,URSODIOL,https://www.dgidb.org/drugs/rxcui:11065,,FOS,https://www.dgidb.org/genes/hgnc:3796,,,2353.0,FOS,9606.0,Homo sapiens (human),,,,,,,,
58,1291943,31401,Drug Gene Interaction database (DGIdb),Ursodiol,,URSODIOL,https://www.dgidb.org/drugs/rxcui:11065,,BCL2,https://www.dgidb.org/genes/hgnc:990,,,596.0,BCL2,9606.0,Homo sapiens (human),,,,,,,,
59,1291944,31401,Drug Gene Interaction database (DGIdb),Ursodiol,,URSODIOL,https://www.dgidb.org/drugs/rxcui:11065,,E2F1,https://www.dgidb.org/genes/hgnc:3113,,,1869.0,E2F1,9606.0,Homo sapiens (human),,,,,,,,
60,1291945,31401,Drug Gene Interaction database (DGIdb),Ursodiol,,URSODIOL,https://www.dgidb.org/drugs/rxcui:11065,,CYP27A1,https://www.dgidb.org/genes/hgnc:2605,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),,,,,,,,
61,1291946,31401,Drug Gene Interaction database (DGIdb),Ursodiol,,URSODIOL,https://www.dgidb.org/drugs/rxcui:11065,,SLC23A2,https://www.dgidb.org/genes/hgnc:10973,,,9962.0,SLC23A2,9606.0,Homo sapiens (human),,,,,,,,
62,1292538,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,2267,FGL1,https://ctdbase.org/detail.go?type=gene&acc=2267,,,2267.0,FGL1,9606.0,Homo sapiens (human),Ursodeoxycholic acid affects the expression of FGL1 mRNA,,,PMID:18422935,https://www.ncbi.nlm.nih.gov/pubmed/18422935,18422935,,
63,1292695,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10434,LYPLA1,https://ctdbase.org/detail.go?type=gene&acc=10434,,,10434.0,LYPLA1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of LYPLA1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
64,1292394,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,9606.0,Homo sapiens (human),Dihydro-beta-erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]|dihydro-beta-erythroidine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]|carbachol inhibits the reaction [dihydro-beta-erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]|dihydro-beta-erythroidine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]],,,PMID:14645658,https://www.ncbi.nlm.nih.gov/pubmed/14645658,14645658,,
65,1292395,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,9606.0,Homo sapiens (human),Dihydro-beta-erythroidine inhibits the reaction [1-butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]],,,PMID:12604691,https://www.ncbi.nlm.nih.gov/pubmed/12604691,12604691,,
66,1292396,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10090.0,Mus musculus (house mouse),Dihydro-beta-erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein],,,PMID:20100906,https://www.ncbi.nlm.nih.gov/pubmed/20100906,20100906,,
67,1292397,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10090.0,Mus musculus (house mouse),Dihydro-beta-erythroidine results in decreased activity of [CHRNA4 protein alternative form binds to CHRNB2 protein alternative form]|dihydro-beta-erythroidine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]|dihydro-beta-erythroidine inhibits the reaction [3-(2-(pyrrolidinyl)methoxy)pyridine analog results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]],,,PMID:16569710,https://www.ncbi.nlm.nih.gov/pubmed/16569710,16569710,,
68,1292398,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116.0,Rattus norvegicus (Norway rat),[CHRNA4 protein binds to CHRNB4 protein] which binds to dihydro-beta-erythroidine,,,PMID:9687574,https://www.ncbi.nlm.nih.gov/pubmed/9687574,9687574,,
69,1292399,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116.0,Rattus norvegicus (Norway rat),Dihydro-beta-erythroidine affects the activity of [CHRNA4 protein binds to CHRNB2 protein],,,PMID:19047205,https://www.ncbi.nlm.nih.gov/pubmed/19047205,19047205,,
70,1292400,31762,Comparative Toxicogenomics Database (CTD),Dihydro-beta-erythroidine,D004079,Dihydro-beta-Erythroidine,https://ctdbase.org/detail.go?type=chem&acc=D004079,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116.0,Rattus norvegicus (Norway rat),Dihydro-beta-erythroidine analog inhibits the reaction [nicotine results in increased expression of CHRNA4 mrna],,,PMID:28555334,https://www.ncbi.nlm.nih.gov/pubmed/28555334,28555334,,
71,1291764,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,239081,TLR11,https://ctdbase.org/detail.go?type=gene&acc=239081,,,239081.0,Tlr11,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLR11 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
72,1291765,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4071,TM4SF1,https://ctdbase.org/detail.go?type=gene&acc=4071,,,4071.0,TM4SF1,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of TM4SF1 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
73,1291766,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,79853,TM4SF20,https://ctdbase.org/detail.go?type=gene&acc=79853,,,79853.0,TM4SF20,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TM4SF20 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
74,1291767,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,53346,TM6SF1,https://ctdbase.org/detail.go?type=gene&acc=53346,,,53346.0,TM6SF1,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of TM6SF1 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
75,1291768,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,53345,TM6SF2,https://ctdbase.org/detail.go?type=gene&acc=53345,,,53345.0,TM6SF2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TM6SF2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
76,1291769,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMED5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
77,1291770,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,54732,TMED9,https://ctdbase.org/detail.go?type=gene&acc=54732,,,54732.0,TMED9,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMED9 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
78,1291771,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,338773,TMEM119,https://ctdbase.org/detail.go?type=gene&acc=338773,,,338773.0,TMEM119,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of TMEM119 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
79,1292235,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,4987,OPRL1,https://ctdbase.org/detail.go?type=gene&acc=4987,,,4987.0,OPRL1,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in decreased expression of OPRL1 mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
80,1292236,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in decreased expression of OPRM1 mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
81,1292237,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,26254,OPTC,https://ctdbase.org/detail.go?type=gene&acc=26254,,,26254.0,OPTC,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in increased expression of OPTC mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
82,1292238,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,258284,OR14J3,https://ctdbase.org/detail.go?type=gene&acc=258284,,,258284.0,Or14j3,10090.0,Mus musculus (house mouse),"2,3,7,8-tetrachlorodibenzofuran affects the expression of OR14J3 mRNA",,,PMID:20702594,https://www.ncbi.nlm.nih.gov/pubmed/20702594,20702594,,
83,1107587,42890,Drug Gene Interaction database (DGIdb),Idarubicin,,IDARUBICIN,https://www.dgidb.org/drugs/rxcui:5650,,CYBA,https://www.dgidb.org/genes/hgnc:2577,,,1535.0,CYBA,9606.0,Homo sapiens (human),,,,,,,,
84,1177891,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,2273,FHL1,https://ctdbase.org/detail.go?type=gene&acc=2273,,,2273.0,FHL1,10116.0,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in increased expression of FHL1 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
85,1177892,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,2274,FHL2,https://ctdbase.org/detail.go?type=gene&acc=2274,,,2274.0,FHL2,10116.0,Rattus norvegicus (Norway rat),Topotecan results in increased expression of FHL2 mrna|[oxaliplatin co-treated with topotecan] results in increased expression of FHL2 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
86,1177893,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,2275,FHL3,https://ctdbase.org/detail.go?type=gene&acc=2275,,,2275.0,FHL3,10116.0,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in increased expression of FHL3 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
87,1107748,62748,Toxin and Toxin Target Database (T3DB),Cobalt dihydroxide,T3D0662,Cobalt(II) hydroxide,http://www.t3db.ca/toxins/T3D0662,BE0005099,Voltage-dependent R-type calcium channel subunit alpha-1E,http://www.t3db.ca/biodb/bio_entities/BE0005099,Q15878,Voltage-dependent R-type calcium channel subunit alpha-1E,777.0,CACNA1E,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
88,1107749,62748,Toxin and Toxin Target Database (T3DB),Cobalt dihydroxide,T3D0662,Cobalt(II) hydroxide,http://www.t3db.ca/toxins/T3D0662,BE0000679,Voltage-dependent calcium channel gamma-1 subunit,http://www.t3db.ca/biodb/bio_entities/BE0000679,Q06432,Voltage-dependent calcium channel gamma-1 subunit,786.0,CACNG1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
89,1107588,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1395,CRHR2,https://ctdbase.org/detail.go?type=gene&acc=1395,,,1395.0,CRHR2,9031.0,Gallus gallus (chicken),Perfluoroundecanoic acid results in increased expression of CRHR2 mRNA,,,PMID:23602845,https://www.ncbi.nlm.nih.gov/pubmed/23602845,23602845,,
90,1107589,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1412,CRYBA2,https://ctdbase.org/detail.go?type=gene&acc=1412,,,1412.0,CRYBA2,9031.0,Gallus gallus (chicken),Perfluoroundecanoic acid results in increased expression of CRYBA2 mRNA,,,PMID:23602845,https://www.ncbi.nlm.nih.gov/pubmed/23602845,23602845,,
91,1107590,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,27254,CSDC2,https://ctdbase.org/detail.go?type=gene&acc=27254,,,27254.0,CSDC2,9031.0,Gallus gallus (chicken),Perfluoroundecanoic acid results in decreased expression of CSDC2 mRNA,,,PMID:23602845,https://www.ncbi.nlm.nih.gov/pubmed/23602845,23602845,,
92,1107591,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,9606.0,Homo sapiens (human),Perfluoroundecanoic acid results in decreased expression of CSF1 protein,,,PMID:32916415,https://www.ncbi.nlm.nih.gov/pubmed/32916415,32916415,,
93,1107592,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1476,CSTB,https://ctdbase.org/detail.go?type=gene&acc=1476,,,1476.0,CSTB,9606.0,Homo sapiens (human),Perfluoroundecanoic acid results in decreased expression of CSTB protein,,,PMID:32916415,https://www.ncbi.nlm.nih.gov/pubmed/32916415,32916415,,
94,1107593,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9031.0,Gallus gallus (chicken),Perfluoroundecanoic acid results in increased expression of CXCL8 mRNA,,,PMID:23602845,https://www.ncbi.nlm.nih.gov/pubmed/23602845,23602845,,
95,1107594,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,9031.0,Gallus gallus (chicken),Perfluoroundecanoic acid results in decreased expression of CYB5A mRNA,,,PMID:23602845,https://www.ncbi.nlm.nih.gov/pubmed/23602845,23602845,,
96,1107595,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Perfluoroundecanoic acid results in decreased expression of CYP11A1 mrna|perfluoroundecanoic acid results in decreased expression of CYP11A1 protein,,,PMID:33549592|PMID:35143807,https://www.ncbi.nlm.nih.gov/pubmed/33549592|https://www.ncbi.nlm.nih.gov/pubmed/35143807,33549592|35143807,,
97,1107596,77222,Comparative Toxicogenomics Database (CTD),Perfluoroundecanoic acid,C586085,perfluoroundecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C586085,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10116.0,Rattus norvegicus (Norway rat),Perfluoroundecanoic acid results in decreased expression of CYP17A1 mrna|perfluoroundecanoic acid results in decreased expression of CYP17A1 protein,,,PMID:33549592|PMID:35143807,https://www.ncbi.nlm.nih.gov/pubmed/33549592|https://www.ncbi.nlm.nih.gov/pubmed/35143807,33549592|35143807,,
98,1177889,188914,Comparative Toxicogenomics Database (CTD),"N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(dimethylamino)ethylamine",C097963,"N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin",https://ctdbase.org/detail.go?type=chem&acc=C097963,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),"N-(2-(3,4-dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [dimemorfan inhibits the reaction [kainic acid results in increased expression of JUN mrna]]|n-(2-(3,4-dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [dimemorfan inhibits the reaction [kainic acid results in increased expression of JUN protein]]|n-(2-(3,4-dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [dextromethorphan inhibits the reaction [kainic acid results in increased expression of JUN mrna]]|n-(2-(3,4-dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [dextromethorphan inhibits the reaction [kainic acid results in increased expression of JUN protein]]",,,PMID:15723099,https://www.ncbi.nlm.nih.gov/pubmed/15723099,15723099,,
99,1177890,188914,Comparative Toxicogenomics Database (CTD),"N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(dimethylamino)ethylamine",C097963,"N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin",https://ctdbase.org/detail.go?type=chem&acc=C097963,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),"N-(2-(3,4-dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]",,,PMID:20354174,https://www.ncbi.nlm.nih.gov/pubmed/20354174,20354174,,
100,1831434,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),"[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide co-treated with [potassium dichromate results in increased abundance of chromium hexavalent ion]] results in increased acetylation of TP53 protein|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased acetylation of TP53 protein",,,PMID:35307491,https://www.ncbi.nlm.nih.gov/pubmed/35307491,35307491,,
101,1831435,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,84676,TRIM63,https://ctdbase.org/detail.go?type=gene&acc=84676,,,84676.0,TRIM63,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [doxorubicin results in increased expression of TRIM63 protein]]",,,PMID:25665036|PMID:26450947,https://www.ncbi.nlm.nih.gov/pubmed/25665036|https://www.ncbi.nlm.nih.gov/pubmed/26450947,25665036|26450947,,
102,1831436,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [cisplatin results in increased acetylation of TRP53 protein]]|pifithrin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [cisplatin results in increased acetylation of TRP53 protein]]]",,,PMID:21593185,https://www.ncbi.nlm.nih.gov/pubmed/21593185,21593185,,
103,1831437,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [doxorubicin results in increased expression of TRP53 protein]]",,,PMID:25665036,https://www.ncbi.nlm.nih.gov/pubmed/25665036,25665036,,
104,1831438,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [antimycin A results in increased acetylation of TRP53 protein]",,,PMID:24040102,https://www.ncbi.nlm.nih.gov/pubmed/24040102,24040102,,
105,1831945,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10116.0,Rattus norvegicus (Norway rat),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [dietary fats results in increased expression of VIM protein]",,,PMID:31981641,https://www.ncbi.nlm.nih.gov/pubmed/31981641,31981641,,
106,1831946,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,89780,WNT3A,https://ctdbase.org/detail.go?type=gene&acc=89780,,,89780.0,WNT3A,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol results in decreased expression of WNT3A mrna]",,,PMID:29990529,https://www.ncbi.nlm.nih.gov/pubmed/29990529,29990529,,
107,1831947,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of CLDN1 protein]|lithocholic acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of OCLN protein]]|lithocholic acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of CDH1 protein]]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of OCLN protein]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of CDH1 protein]|lithocholic acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]]|lithocholic acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of CLDN1 protein]]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]",,,PMID:31472180,https://www.ncbi.nlm.nih.gov/pubmed/31472180,31472180,,
108,1831948,5113032,Comparative Toxicogenomics Database (CTD),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [catalpol inhibits the reaction [lipopolysaccharides results in increased expression of TNF protein]]",,,PMID:37436358,https://www.ncbi.nlm.nih.gov/pubmed/37436358,37436358,,
109,1831949,5115028,BindingDB,1-Formyl-3-phenyl-5-(2-nitrophenyl)-2-pyrazoline,120827,N-formyl-5-(-2&#39;-nitrophenyl)-3-phenylpyrazoline (1h),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=120827,6181,Cathepsin H,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6181,,,,,,,,Ki (nM),0.963,PMID:25181676|DOI:10.1016/j.bioorg.2014.07.012,https://www.ncbi.nlm.nih.gov/pubmed/25181676|https://doi.org/10.1016/j.bioorg.2014.07.012,25181676,10.1016/j.bioorg.2014.07.012,
110,1831950,5115028,BindingDB,1-Formyl-3-phenyl-5-(2-nitrophenyl)-2-pyrazoline,120827,N-formyl-5-(-2&#39;-nitrophenyl)-3-phenylpyrazoline (1h),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=120827,6180,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6180,,,,,,,,Ki (nM),0.141,PMID:25181676|DOI:10.1016/j.bioorg.2014.07.012,https://www.ncbi.nlm.nih.gov/pubmed/25181676|https://doi.org/10.1016/j.bioorg.2014.07.012,25181676,10.1016/j.bioorg.2014.07.012,
111,1832125,5280360,Therapeutic Target Database (TTD),Dinoprostone,D06FEA,Dinoprostone,https://idrblab.net/ttd/data/drug/details/D06FEA,T75797,Prostaglandin F2-alpha receptor (PTGFR),https://idrblab.net/ttd/data/target/details/T75797,P43088,Prostaglandin F2-alpha receptor,5737.0,PTGFR,9606.0,Homo sapiens (human),Antagonist,,,,,,,
112,1832126,5280360,Therapeutic Target Database (TTD),Dinoprostone,D06FEA,Dinoprostone,https://idrblab.net/ttd/data/drug/details/D06FEA,T38529,Prostaglandin E2 receptor EP2 (PTGER2),https://idrblab.net/ttd/data/target/details/T38529,P43116,Prostaglandin E2 receptor EP2 subtype,5732.0,PTGER2,9606.0,Homo sapiens (human),Antagonist,,,,,,,
113,1832127,5280360,Drug Gene Interaction database (DGIdb),Dinoprostone,,DINOPROSTONE,https://www.dgidb.org/drugs/rxcui:3478,,PTGER3,https://www.dgidb.org/genes/hgnc:9595,,,5733.0,PTGER3,9606.0,Homo sapiens (human),,,,,,,,
114,1832128,5280360,Drug Gene Interaction database (DGIdb),Dinoprostone,,DINOPROSTONE,https://www.dgidb.org/drugs/rxcui:3478,,PTGER1,https://www.dgidb.org/genes/hgnc:9593,,,5731.0,PTGER1,9606.0,Homo sapiens (human),,,,,,,,
115,1832129,5280373,Drug Gene Interaction database (DGIdb),Biochanin A,,BIOCHANIN A,https://www.dgidb.org/drugs/drugbank:DB15334,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
116,1832130,5280373,Drug Gene Interaction database (DGIdb),Biochanin A,,BIOCHANIN A,https://www.dgidb.org/drugs/drugbank:DB15334,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
117,1832131,5280373,Drug Gene Interaction database (DGIdb),Biochanin A,,BIOCHANIN A,https://www.dgidb.org/drugs/drugbank:DB15334,,SMN2,https://www.dgidb.org/genes/hgnc:11118,,,6607.0,SMN2,9606.0,Homo sapiens (human),,,,,,,,
118,1832132,5280388,Drug Gene Interaction database (DGIdb),prostaglandin B1,,PROSTAGLANDIN B1,https://www.dgidb.org/drugs/chembl:CHEMBL1561148,,RECQL,https://www.dgidb.org/genes/hgnc:9948,,,5965.0,RECQL,9606.0,Homo sapiens (human),,,,,,,,
119,1832133,5280388,Drug Gene Interaction database (DGIdb),prostaglandin B1,,PROSTAGLANDIN B1,https://www.dgidb.org/drugs/chembl:CHEMBL1561148,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
120,1832320,5280445,Therapeutic Target Database (TTD),Luteolin,D04AIT,B-Lactams,https://idrblab.net/ttd/data/drug/details/D04AIT,T30653,Acetyl-CoA:lyso-PAF acetyltransferase (PCAT),https://idrblab.net/ttd/data/target/details/T30653,Q8NF37,Lysophosphatidylcholine acyltransferase 1,79888.0,LPCAT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
121,1832321,5280445,Therapeutic Target Database (TTD),Luteolin,D04AIT,B-Lactams,https://idrblab.net/ttd/data/drug/details/D04AIT,T30653,Acetyl-CoA:lyso-PAF acetyltransferase (PCAT),https://idrblab.net/ttd/data/target/details/T30653,Q7L5N7,Lysophosphatidylcholine acyltransferase 2,54947.0,LPCAT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
122,1832322,5280450,Drug Gene Interaction database (DGIdb),Linoleic Acid,,LINOLEIC ACID,https://www.dgidb.org/drugs/rxcui:6400,,HPGD,https://www.dgidb.org/genes/hgnc:5154,,,3248.0,HPGD,9606.0,Homo sapiens (human),,,,,,,,
123,1832323,5280453,Therapeutic Target Database (TTD),Calcitriol,D0T2PL,Calcitriol,https://idrblab.net/ttd/data/drug/details/D0T2PL,T34234,Vitamin D3 receptor (VDR),https://idrblab.net/ttd/data/target/details/T34234,P11473,Vitamin D3 receptor,7421.0,VDR,9606.0,Homo sapiens (human),Agonist,,,,,,,
124,1832324,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,C097949,"1,25-dihydroxyvitamin D",https://ctdbase.org/detail.go?type=chem&acc=C097949,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,9606.0,Homo sapiens (human),"VDR protein affects the reaction [1,25-dihydroxyvitamin D results in increased degradation of and results in decreased expression of MYC protein]|1,25-dihydroxyvitamin D promotes the reaction [MYC protein binds to VDR protein]|1,25-dihydroxyvitamin D inhibits the reaction [VDR protein binds to CDC25A enhancer]|1,25-dihydroxyvitamin D promotes the reaction [MXD1 protein binds to VDR protein]",,,PMID:23112173,https://www.ncbi.nlm.nih.gov/pubmed/23112173,23112173,,
125,1832325,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,C097949,"1,25-dihydroxyvitamin D",https://ctdbase.org/detail.go?type=chem&acc=C097949,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,9606.0,Homo sapiens (human),"Bisindolylmaleimide I inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]|1,25-dihydroxyvitamin D results in increased activity of VDR protein|hras protein inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]]|go 6976 inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]",,,PMID:18829283,https://www.ncbi.nlm.nih.gov/pubmed/18829283,18829283,,
126,1831478,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10090.0,Mus musculus (house mouse),[glucose deficiency co-treated with alpha-linolenic acid] results in increased expression of PCK1 mRNA,,,PMID:8536680,https://www.ncbi.nlm.nih.gov/pubmed/8536680,8536680,,
127,1831479,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10090.0,Mus musculus (house mouse),Alpha-linolenic acid results in increased expression of PLIN2 mrna|alpha-linolenic acid results in increased expression of PLIN2 protein,,,PMID:16489205,https://www.ncbi.nlm.nih.gov/pubmed/16489205,16489205,,
128,1831480,5280953,Drug Gene Interaction database (DGIdb),Harmine,,HARMINE,https://www.dgidb.org/drugs/ncit:C97713,,CLK1,https://www.dgidb.org/genes/hgnc:2068,,,1195.0,CLK1,9606.0,Homo sapiens (human),,,,,,,,
129,1831481,5280961,Drug Gene Interaction database (DGIdb),Genistein,,GENISTEIN,https://www.dgidb.org/drugs/rxcui:25696,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
130,1830852,5282102,Comparative Toxicogenomics Database (CTD),Astragalin,C001579,astragalin,https://ctdbase.org/detail.go?type=chem&acc=C001579,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Astragalin inhibits the reaction [[galactose co-treated with aluminum chloride] results in increased expression of IL6 protein],,,PMID:35537655,https://www.ncbi.nlm.nih.gov/pubmed/35537655,35537655,,
131,1830853,5282102,Comparative Toxicogenomics Database (CTD),Astragalin,C001579,astragalin,https://ctdbase.org/detail.go?type=chem&acc=C001579,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Astragalin inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna],,,PMID:22210036,https://www.ncbi.nlm.nih.gov/pubmed/22210036,22210036,,
132,1830854,5282102,Comparative Toxicogenomics Database (CTD),Astragalin,C001579,astragalin,https://ctdbase.org/detail.go?type=chem&acc=C001579,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),Astragalin inhibits the reaction [lipopolysaccharides results in increased degradation of NFKBIA protein],,,PMID:22210036,https://www.ncbi.nlm.nih.gov/pubmed/22210036,22210036,,
133,1832012,5284371,Drug Gene Interaction database (DGIdb),Codeine,,CODEINE ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1545976,,SLC22A1,https://www.dgidb.org/genes/hgnc:10963,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),,,,,,,,
134,1832013,5284373,IUPHAR/BPS Guide to PHARMACOLOGY,cyclosporin A,1024,cyclosporin A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,1221,OATP1B3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1221,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Inhibition,pIC50,6.1,PMID:17496208|PMID:22541068,https://www.ncbi.nlm.nih.gov/pubmed/17496208|https://www.ncbi.nlm.nih.gov/pubmed/22541068,17496208|22541068,,
135,1832014,5284373,IUPHAR/BPS Guide to PHARMACOLOGY,cyclosporin A,1024,cyclosporin A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,1220,OATP1B1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1220,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Inhibition,pKi,7.29,PMID:14530907|PMID:22541068,https://www.ncbi.nlm.nih.gov/pubmed/14530907|https://www.ncbi.nlm.nih.gov/pubmed/22541068,14530907|22541068,,
136,1832015,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ATF3 protein,,,PMID:19159671,https://www.ncbi.nlm.nih.gov/pubmed/19159671,19159671,,
137,1832016,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of ATF3 mRNA,,,PMID:23958496|PMID:27585667,https://www.ncbi.nlm.nih.gov/pubmed/23958496|https://www.ncbi.nlm.nih.gov/pubmed/27585667,23958496|27585667,,
138,1832017,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),Ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [cyclosporine results in increased expression of ATF3 mrna]|tlr4 gene mutant form inhibits the reaction [cyclosporine results in increased expression of ATF3 mrna],,,PMID:27585667,https://www.ncbi.nlm.nih.gov/pubmed/27585667,27585667,,
139,1832018,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in increased expression of ATF3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
140,1832019,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),Cyclosporine affects the activity of ATF4 protein,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
141,1832020,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),[cyclosporine co-treated with cholic acids] affects the expression of ATF4 mRNA,,,PMID:27344345,https://www.ncbi.nlm.nih.gov/pubmed/27344345,27344345,,
142,1832602,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,9606.0,Homo sapiens (human),[cyclosporine co-treated with glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid] results in increased expression of ATG7 mRNA,,,PMID:32152650,https://www.ncbi.nlm.nih.gov/pubmed/32152650,32152650,,
143,1832603,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ATG7 mRNA,,,PMID:32152650|PMID:34681664,https://www.ncbi.nlm.nih.gov/pubmed/32152650|https://www.ncbi.nlm.nih.gov/pubmed/34681664,32152650|34681664,,
144,1831084,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),T-2 toxin results in increased phosphorylation of MAPK1 protein,,,PMID:36775139,https://www.ncbi.nlm.nih.gov/pubmed/36775139,36775139,,
145,1831085,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,6300,MAPK12,https://ctdbase.org/detail.go?type=gene&acc=6300,,,6300.0,MAPK12,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MAPK12 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
146,1831086,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MAPK3 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
147,1831087,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10090.0,Mus musculus (house mouse),T-2 toxin results in increased phosphorylation of MAPK8 protein,,,PMID:36775139,https://www.ncbi.nlm.nih.gov/pubmed/36775139,36775139,,
148,1831088,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,9479,MAPK8IP1,https://ctdbase.org/detail.go?type=gene&acc=9479,,,9479.0,MAPK8IP1,9606.0,Homo sapiens (human),T-2 toxin results in increased expression of MAPK8IP1 mRNA,,,PMID:34581912,https://www.ncbi.nlm.nih.gov/pubmed/34581912,34581912,,
149,1831089,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,23162,MAPK8IP3,https://ctdbase.org/detail.go?type=gene&acc=23162,,,23162.0,MAPK8IP3,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MAPK8IP3 mRNA,,,PMID:36695871,https://www.ncbi.nlm.nih.gov/pubmed/36695871,36695871,,
150,1831090,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MAPK9 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
151,1831091,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,10982,MAPRE2,https://ctdbase.org/detail.go?type=gene&acc=10982,,,10982.0,MAPRE2,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MAPRE2 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
152,1831429,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,64087,MCCC2,https://ctdbase.org/detail.go?type=gene&acc=64087,,,64087.0,MCCC2,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MCCC2 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
153,1831430,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263.0,MCF2L,10116.0,Rattus norvegicus (Norway rat),T-2 toxin results in decreased expression of MCF2L mRNA,,,PMID:26141394,https://www.ncbi.nlm.nih.gov/pubmed/26141394,26141394,,
154,1831431,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MCM4 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
155,1831432,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,4176,MCM7,https://ctdbase.org/detail.go?type=gene&acc=4176,,,4176.0,MCM7,10116.0,Rattus norvegicus (Norway rat),T-2 toxin affects the expression of MCM7 protein,,,PMID:26141394,https://www.ncbi.nlm.nih.gov/pubmed/26141394,26141394,,
156,1831433,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,255231,MCOLN2,https://ctdbase.org/detail.go?type=gene&acc=255231,,,255231.0,MCOLN2,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MCOLN2 mRNA,,,PMID:36695871,https://www.ncbi.nlm.nih.gov/pubmed/36695871,36695871,,
157,1832181,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,54069,MIS18A,https://ctdbase.org/detail.go?type=gene&acc=54069,,,54069.0,MIS18A,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MIS18A mRNA,,,PMID:36695871,https://www.ncbi.nlm.nih.gov/pubmed/36695871,36695871,,
158,1832182,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9031.0,Gallus gallus (chicken),T-2 toxin results in increased expression of MKI67 mRNA,,,PMID:36695871,https://www.ncbi.nlm.nih.gov/pubmed/36695871,36695871,,
159,1832183,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,2872,MKNK2,https://ctdbase.org/detail.go?type=gene&acc=2872,,,2872.0,MKNK2,9606.0,Homo sapiens (human),T-2 toxin results in decreased expression of MKNK2 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
160,1832184,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,283078,MKX,https://ctdbase.org/detail.go?type=gene&acc=283078,,,283078.0,MKX,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MKX mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
161,1832185,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,4298,MLLT1,https://ctdbase.org/detail.go?type=gene&acc=4298,,,4298.0,MLLT1,9031.0,Gallus gallus (chicken),T-2 toxin results in decreased expression of MLLT1 mRNA,,,PMID:31299295,https://www.ncbi.nlm.nih.gov/pubmed/31299295,31299295,,
162,1831124,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,158399,ZNF483,https://ctdbase.org/detail.go?type=gene&acc=158399,,,158399.0,ZNF483,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ZNF483 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
163,1831125,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,85460,ZNF518B,https://ctdbase.org/detail.go?type=gene&acc=85460,,,85460.0,ZNF518B,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ZNF518B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
164,1831126,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,25925,ZNF521,https://ctdbase.org/detail.go?type=gene&acc=25925,,,25925.0,ZNF521,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ZNF521 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
165,1831127,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,64763,ZNF574,https://ctdbase.org/detail.go?type=gene&acc=64763,,,64763.0,ZNF574,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ZNF574 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
166,1831128,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,80095,ZNF606,https://ctdbase.org/detail.go?type=gene&acc=80095,,,80095.0,ZNF606,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ZNF606 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
167,1831129,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,57507,ZNF608,https://ctdbase.org/detail.go?type=gene&acc=57507,,,57507.0,ZNF608,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ZNF608 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
168,1831891,5289214,DrugBank,N-[1-(4-Carbamimidoyl-benzylcarbamoyl)-3-methylsulfanyl-propyl]-3-hydroxy-2-propoxyamino-butyramid,DB04767,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,https://www.drugbank.ca/drugs/DB04767,BE0000333,Coagulation factor VII,https://www.drugbank.ca/bio_entities/BE0000333,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,,,,,,,
169,1831892,5289247,DrugBank,"5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione",DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",https://www.drugbank.ca/drugs/DB04769,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",https://www.drugbank.ca/bio_entities/BE0001315,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
170,1832059,5289547,DrugBank,Becocalcidiol,DB04891,Becocalcidiol,https://www.drugbank.ca/drugs/DB04891,BE0000779,Vitamin D3 receptor,https://www.drugbank.ca/bio_entities/BE0000779,P11473,Vitamin D3 receptor,7421.0,VDR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
171,1832060,5289562,DrugBank,3-[[N-[4-Methyl-piperazinyl]carbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic acid benzyloxy-amide,DB04427,N-{(3S)-1-[(Benzyloxy)sulfamoyl]-5-phenyl-3-pentanyl}-Nα-[(4-methyl-1-piperazinyl)carbonyl]-L-phenylalaninamide,https://www.drugbank.ca/drugs/DB04427,BE0001292,Cruzipain,https://www.drugbank.ca/bio_entities/BE0001292,P25779,Cruzipain,,,5693.0,Trypanosoma cruzi,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
172,1832264,5289570,DrugBank,"Methyl(6S)-1-thio-L-manno-hexodialdo-6,2-pyranoside",DB04508,"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",https://www.drugbank.ca/drugs/DB04508,BE0001978,Hemagglutinin-neuraminidase,https://www.drugbank.ca/bio_entities/BE0001978,P32884,Hemagglutinin-neuraminidase,,,11178.0,Newcastle disease virus strain Beaudette C/45,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
173,1832458,5310987,Comparative Toxicogenomics Database (CTD),(E)-4-Amino-2-butenoic acid,C055331,4-aminocrotonic acid,https://ctdbase.org/detail.go?type=chem&acc=C055331,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116.0,Rattus norvegicus (Norway rat),"(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]]|4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]",,,PMID:14535961,https://www.ncbi.nlm.nih.gov/pubmed/14535961,14535961,,
174,1832459,5311036,Comparative Toxicogenomics Database (CTD),BW 723C86 hydrochloride,C092430,1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine,https://ctdbase.org/detail.go?type=chem&acc=C092430,3357,HTR2B,https://ctdbase.org/detail.go?type=gene&acc=3357,,,3357.0,HTR2B,9606.0,Homo sapiens (human),1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine binds to and results in increased activity of HTR2B protein,,,PMID:21414306,https://www.ncbi.nlm.nih.gov/pubmed/21414306,21414306,,
175,1832460,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C477819,15-deoxyprostaglandin J2,https://ctdbase.org/detail.go?type=chem&acc=C477819,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606.0,Homo sapiens (human),15-deoxyprostaglandin J2 results in decreased localization of EP300 protein,,,PMID:15641079,https://www.ncbi.nlm.nih.gov/pubmed/15641079,15641079,,
176,1832461,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),"15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of COL1A1 mRNA",,,PMID:12021203,https://www.ncbi.nlm.nih.gov/pubmed/12021203,12021203,,
177,1832462,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),"Dexamethasone promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mrna]]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mrna]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 protein]",,,PMID:14998300,https://www.ncbi.nlm.nih.gov/pubmed/14998300,14998300,,
178,1832463,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [lipopolysaccharides results in increased expression of CSF2 mrna]",,,PMID:12604364,https://www.ncbi.nlm.nih.gov/pubmed/12604364,12604364,,
179,1832464,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in decreased degradation of CXCL8 mrna]",,,PMID:18485432,https://www.ncbi.nlm.nih.gov/pubmed/18485432,18485432,,
180,1832465,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CXCL8 mrna]",,,PMID:14998300,https://www.ncbi.nlm.nih.gov/pubmed/14998300,14998300,,
181,1832466,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[poly I-C co-treated with IL4 protein] results in increased expression of CXCL8 mrna]",,,PMID:23688403,https://www.ncbi.nlm.nih.gov/pubmed/23688403,23688403,,
182,1831764,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] results in decreased secretion of IL1B protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
183,1831765,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Icariin affects the expression of IL6 protein,,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
184,1831766,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] results in decreased secretion of IL6 protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
185,1831767,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Icariin results in increased expression of JUN mrna|icariin results in increased expression of JUN protein|u 0126 inhibits the reaction [icariin results in increased expression of JUN protein]|sb 203580 inhibits the reaction [icariin results in increased expression of JUN protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
186,1831768,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Icariin results in increased phosphorylation of MAPK1 protein|u 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK1 protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
187,1831769,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Icariin results in increased phosphorylation of MAPK3 protein|u 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK3 protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
188,1831770,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,4208,MEF2C,https://ctdbase.org/detail.go?type=gene&acc=4208,,,4208.0,MEF2C,10090.0,Mus musculus (house mouse),U 0126 inhibits the reaction [icariin results in increased expression of MEF2C mrna]|icariin affects the localization of MEF2C protein|sb 203580 inhibits the reaction [icariin results in increased expression of MEF2C mrna]|u 0126 inhibits the reaction [icariin affects the localization of MEF2C protein]|icariin results in increased expression of MEF2C mrna|sb 203580 inhibits the reaction [icariin affects the localization of MEF2C protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
189,1831771,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,100187716,MIR1224,https://ctdbase.org/detail.go?type=gene&acc=100187716,,,100187716.0,MIR1224,10090.0,Mus musculus (house mouse),Icariin results in decreased expression of MIR1224 mRNA,,,PMID:30533443,https://www.ncbi.nlm.nih.gov/pubmed/30533443,30533443,,
190,1831772,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,406931,MIR139,https://ctdbase.org/detail.go?type=gene&acc=406931,,,406931.0,MIR139,10090.0,Mus musculus (house mouse),Icariin results in decreased expression of MIR139 mRNA,,,PMID:30533443,https://www.ncbi.nlm.nih.gov/pubmed/30533443,30533443,,
191,1831773,5318997,Comparative Toxicogenomics Database (CTD),Icariin,C056599,icariin,https://ctdbase.org/detail.go?type=chem&acc=C056599,406932,MIR140,https://ctdbase.org/detail.go?type=gene&acc=406932,,,406932.0,MIR140,10090.0,Mus musculus (house mouse),Icariin results in decreased expression of MIR140 mRNA,,,PMID:30533443,https://www.ncbi.nlm.nih.gov/pubmed/30533443,30533443,,
192,1831122,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,5293,PIK3CD,https://ctdbase.org/detail.go?type=gene&acc=5293,,,5293.0,PIK3CD,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PIK3CD mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
193,1831123,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,113791,PIK3IP1,https://ctdbase.org/detail.go?type=gene&acc=113791,,,113791.0,PIK3IP1,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of PIK3IP1 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
194,1831482,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,55529,PIP4P2,https://ctdbase.org/detail.go?type=gene&acc=55529,,,55529.0,PIP4P2,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PIP4P2 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
195,1831483,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,8395,PIP5K1B,https://ctdbase.org/detail.go?type=gene&acc=8395,,,8395.0,PIP5K1B,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PIP5K1B mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
196,1831484,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of PIR mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
197,1831485,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,23760,PITPNB,https://ctdbase.org/detail.go?type=gene&acc=23760,,,23760.0,PITPNB,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PITPNB mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
198,1831707,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,5318,PKP2,https://ctdbase.org/detail.go?type=gene&acc=5318,,,5318.0,PKP2,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of PKP2 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
199,1831708,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,8502,PKP4,https://ctdbase.org/detail.go?type=gene&acc=8502,,,8502.0,PKP4,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PKP4 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
200,1831709,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579.0,PLA2G12A,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PLA2G12A mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
201,1831710,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,50487,PLA2G3,https://ctdbase.org/detail.go?type=gene&acc=50487,,,50487.0,PLA2G3,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PLA2G3 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
202,1831711,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,8605,PLA2G4C,https://ctdbase.org/detail.go?type=gene&acc=8605,,,8605.0,PLA2G4C,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PLA2G4C mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
203,1831712,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,8398,PLA2G6,https://ctdbase.org/detail.go?type=gene&acc=8398,,,8398.0,PLA2G6,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PLA2G6 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
204,1831713,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,10761,PLAC1,https://ctdbase.org/detail.go?type=gene&acc=10761,,,10761.0,PLAC1,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of PLAC1 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
205,1831714,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,5324,PLAG1,https://ctdbase.org/detail.go?type=gene&acc=5324,,,5324.0,PLAG1,9606.0,Homo sapiens (human),Sunitinib results in increased expression of PLAG1 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
206,1831092,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Lead results in increased expression of APP protein,,,PMID:21315759|PMID:22272629|PMID:25673500,https://www.ncbi.nlm.nih.gov/pubmed/21315759|https://www.ncbi.nlm.nih.gov/pubmed/22272629|https://www.ncbi.nlm.nih.gov/pubmed/25673500,21315759|22272629|25673500,,
207,1831290,5353303,BindingDB,,13939,2-(2-HYDROXY-5-METHOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13939,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),4600,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
208,1831291,5353303,BindingDB,,13939,2-(2-HYDROXY-5-METHOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13939,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),2500,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
209,1831625,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),170,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
210,1831626,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,5163,Urokinase-type plasminogen activator,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5163,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),,Ki (nM),2300,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
211,1831627,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),3600,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
212,1831628,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),4000,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
213,1831629,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),1100,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
214,1831630,5353306,BindingDB,,13937,2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13937,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),65,PMID:11292354|DOI:10.1006/jmbi.2001.4516,https://www.ncbi.nlm.nih.gov/pubmed/11292354|https://doi.org/10.1006/jmbi.2001.4516,11292354,10.1006/jmbi.2001.4516,
215,1831631,5353365,IUPHAR/BPS Guide to PHARMACOLOGY,8-(3-Chlorostyryl)caffeine,5609,CSC,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5609,18,A1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,P25099,Adenosine receptor A1,29290.0,Adora1,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,4.55,PMID:8496902,https://www.ncbi.nlm.nih.gov/pubmed/8496902,8496902,,
216,1831632,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [nickel sulfate results in increased expression of CD40 protein],,,PMID:17636246,https://www.ncbi.nlm.nih.gov/pubmed/17636246,17636246,,
217,1831633,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [AGT protein results in increased expression of CCL2 mrna],,,PMID:16705055,https://www.ncbi.nlm.nih.gov/pubmed/16705055,16705055,,
218,1832186,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,1269,CNR2,https://ctdbase.org/detail.go?type=gene&acc=1269,,,1269.0,CNR2,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [gemcitabine results in increased expression of CNR2 mrna],,,PMID:21525939,https://www.ncbi.nlm.nih.gov/pubmed/21525939,21525939,,
219,1832187,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [[oligomycins co-treated with IL1B protein] results in increased expression of CXCL8 protein]|bay 11-7085 inhibits the reaction [[antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein],,,PMID:22549761,https://www.ncbi.nlm.nih.gov/pubmed/22549761,22549761,,
220,1832188,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [[IL1B protein co-treated with oligomycins] results in increased expression of CXCL8 protein],,,PMID:24609059,https://www.ncbi.nlm.nih.gov/pubmed/24609059,24609059,,
221,1832189,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),BAY 11-7085 results in increased secretion of CXCL8 protein|bay 11-7085 inhibits the reaction [nickel sulfate results in increased secretion of CXCL8 protein],,,PMID:17636246,https://www.ncbi.nlm.nih.gov/pubmed/17636246,17636246,,
222,1832190,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein],,,PMID:16606632,https://www.ncbi.nlm.nih.gov/pubmed/16606632,16606632,,
223,1832771,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),BAY 11-7085 results in decreased secretion of IL1B protein,,,PMID:25382723|PMID:27297965|PMID:27567548,https://www.ncbi.nlm.nih.gov/pubmed/25382723|https://www.ncbi.nlm.nih.gov/pubmed/27297965|https://www.ncbi.nlm.nih.gov/pubmed/27567548,25382723|27297965|27567548,,
224,1832772,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),BAY 11-7085 inhibits the reaction [particulate matter results in increased expression of IL1B mrna],,,PMID:27393915,https://www.ncbi.nlm.nih.gov/pubmed/27393915,27393915,,
225,1832773,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,246778,IL27,https://ctdbase.org/detail.go?type=gene&acc=246778,,,246778.0,IL27,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [nickel sulfate results in increased expression of IL27 mrna],,,PMID:30421605,https://www.ncbi.nlm.nih.gov/pubmed/30421605,30421605,,
226,1832774,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),"BAY 11-7085 inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 protein]",,,PMID:17015710,https://www.ncbi.nlm.nih.gov/pubmed/17015710,17015710,,
227,1832775,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567.0,IL5,10090.0,Mus musculus (house mouse),"BAY 11-7085 inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL5 protein]",,,PMID:17015710,https://www.ncbi.nlm.nih.gov/pubmed/17015710,17015710,,
228,1832776,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [cadmium chloride results in increased expression of and results in increased secretion of IL6 protein],,,PMID:35122928,https://www.ncbi.nlm.nih.gov/pubmed/35122928,35122928,,
229,1832777,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [nickel sulfate results in increased secretion of IL6 protein],,,PMID:17636246,https://www.ncbi.nlm.nih.gov/pubmed/17636246,17636246,,
230,1832778,5353432,Comparative Toxicogenomics Database (CTD),(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),BAY 11-7085 inhibits the reaction [TNF protein results in increased secretion of IL6 protein],,,PMID:16606632,https://www.ncbi.nlm.nih.gov/pubmed/16606632,16606632,,
231,1831381,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4049,LTA,https://ctdbase.org/detail.go?type=gene&acc=4049,,,4049.0,LTA,9606.0,Homo sapiens (human),Arsenic results in decreased expression of LTA mrna|[arsenic co-treated with fluorides] results in decreased expression of LTA mRNA,,,PMID:19962721,https://www.ncbi.nlm.nih.gov/pubmed/19962721,19962721,,
232,1831382,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4050,LTB,https://ctdbase.org/detail.go?type=gene&acc=4050,,,4050.0,LTB,9606.0,Homo sapiens (human),Arsenic affects the expression of LTB protein,,,PMID:24675094,https://www.ncbi.nlm.nih.gov/pubmed/24675094,24675094,,
233,1831383,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4050,LTB,https://ctdbase.org/detail.go?type=gene&acc=4050,,,4050.0,LTB,9606.0,Homo sapiens (human),[arsenic co-treated with fluorides] results in decreased expression of LTB mRNA,,,PMID:19962721,https://www.ncbi.nlm.nih.gov/pubmed/19962721,19962721,,
234,1831575,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4053,LTBP2,https://ctdbase.org/detail.go?type=gene&acc=4053,,,4053.0,LTBP2,9606.0,Homo sapiens (human),Arsenic affects the methylation of LTBP2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
235,1831576,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4057,LTF,https://ctdbase.org/detail.go?type=gene&acc=4057,,,4057.0,LTF,9606.0,Homo sapiens (human),Arsenic results in decreased expression of LTF protein,,,PMID:19167470,https://www.ncbi.nlm.nih.gov/pubmed/19167470,19167470,,
236,1831577,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4057,LTF,https://ctdbase.org/detail.go?type=gene&acc=4057,,,4057.0,LTF,10090.0,Mus musculus (house mouse),Arsenic results in increased expression of LTF mRNA,,,PMID:19654921,https://www.ncbi.nlm.nih.gov/pubmed/19654921,19654921,,
237,1831578,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4058,LTK,https://ctdbase.org/detail.go?type=gene&acc=4058,,,4058.0,LTK,9606.0,Homo sapiens (human),Arsenic results in increased methylation of LTK gene,,,PMID:24525453,https://www.ncbi.nlm.nih.gov/pubmed/24525453,24525453,,
238,1831579,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,286343,LURAP1L,https://ctdbase.org/detail.go?type=gene&acc=286343,,,286343.0,LURAP1L,9606.0,Homo sapiens (human),Arsenic results in increased methylation of LURAP1L gene,,,PMID:24525453,https://www.ncbi.nlm.nih.gov/pubmed/24525453,24525453,,
239,1831580,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,206338,LVRN,https://ctdbase.org/detail.go?type=gene&acc=206338,,,206338.0,LVRN,9606.0,Homo sapiens (human),Arsenic affects the methylation of LVRN gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
240,1831581,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,8581,LY6D,https://ctdbase.org/detail.go?type=gene&acc=8581,,,8581.0,LY6D,9606.0,Homo sapiens (human),Arsenic affects the methylation of LY6D gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
241,1831582,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,80740,LY6G6C,https://ctdbase.org/detail.go?type=gene&acc=80740,,,80740.0,LY6G6C,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in decreased expression of LY6G6C mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
242,1831583,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9450,LY86,https://ctdbase.org/detail.go?type=gene&acc=9450,,,9450.0,LY86,9606.0,Homo sapiens (human),Arsenic affects the methylation of LY86 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
243,1831584,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4063,LY9,https://ctdbase.org/detail.go?type=gene&acc=4063,,,4063.0,LY9,9606.0,Homo sapiens (human),Arsenic affects the methylation of LY9 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
244,1831893,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,256586,LYSMD2,https://ctdbase.org/detail.go?type=gene&acc=256586,,,256586.0,LYSMD2,9606.0,Homo sapiens (human),Arsenic affects the methylation of LYSMD2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
245,1831894,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,54585,LZTFL1,https://ctdbase.org/detail.go?type=gene&acc=54585,,,54585.0,LZTFL1,9606.0,Homo sapiens (human),Arsenic affects the methylation of LZTFL1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
246,1831895,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,23499,MACF1,https://ctdbase.org/detail.go?type=gene&acc=23499,,,23499.0,MACF1,9606.0,Homo sapiens (human),Arsenic affects the methylation of MACF1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
247,1831896,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,90355,MACIR,https://ctdbase.org/detail.go?type=gene&acc=90355,,,90355.0,MACIR,9606.0,Homo sapiens (human),Arsenic affects the methylation of MACIR gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
248,1831897,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9555,MACROH2A1,https://ctdbase.org/detail.go?type=gene&acc=9555,,,9555.0,MACROH2A1,9606.0,Homo sapiens (human),Arsenic affects the methylation of MACROH2A1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
249,1831898,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9555,MACROH2A1,https://ctdbase.org/detail.go?type=gene&acc=9555,,,9555.0,MACROH2A1,9606.0,Homo sapiens (human),Arsenic results in increased ubiquitination of MACROH2A1 protein,,,PMID:35994080,https://www.ncbi.nlm.nih.gov/pubmed/35994080,35994080,,
250,1831899,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,8379,MAD1L1,https://ctdbase.org/detail.go?type=gene&acc=8379,,,8379.0,MAD1L1,9606.0,Homo sapiens (human),Arsenic affects the methylation of MAD1L1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
251,1832061,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in decreased expression of MAFB mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
252,1832062,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in increased expression of MAFF mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
253,1832063,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4113,MAGEB2,https://ctdbase.org/detail.go?type=gene&acc=4113,,,4113.0,MAGEB2,9606.0,Homo sapiens (human),Arsenic results in increased expression of MAGEB2 mRNA,,,PMID:36861143,https://www.ncbi.nlm.nih.gov/pubmed/36861143,36861143,,
254,1832064,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,54551,MAGEL2,https://ctdbase.org/detail.go?type=gene&acc=54551,,,54551.0,MAGEL2,9606.0,Homo sapiens (human),Arsenic affects the methylation of MAGEL2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
255,1832065,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9223,MAGI1,https://ctdbase.org/detail.go?type=gene&acc=9223,,,9223.0,MAGI1,9606.0,Homo sapiens (human),Arsenic affects the methylation of MAGI1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
256,1832066,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,9863,MAGI2,https://ctdbase.org/detail.go?type=gene&acc=9863,,,9863.0,MAGI2,9606.0,Homo sapiens (human),Arsenic affects the methylation of MAGI2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
257,1832067,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,79917,MAGIX,https://ctdbase.org/detail.go?type=gene&acc=79917,,,79917.0,MAGIX,9606.0,Homo sapiens (human),Arsenic results in increased methylation of MAGIX promoter,,,PMID:21291286,https://www.ncbi.nlm.nih.gov/pubmed/21291286,21291286,,
258,1832068,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,4118,MAL,https://ctdbase.org/detail.go?type=gene&acc=4118,,,4118.0,MAL,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in decreased expression of MAL mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
259,1830851,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760.0,CA2,9606.0,Homo sapiens (human),Enalapril results in decreased activity of CA2 protein,,,PMID:28126276,https://www.ncbi.nlm.nih.gov/pubmed/28126276,28126276,,
260,1831229,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10090.0,Mus musculus (house mouse),Enalapril results in decreased expression of CCN2 mRNA,,,PMID:25037058,https://www.ncbi.nlm.nih.gov/pubmed/25037058,25037058,,
261,1831230,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Enalapril inhibits the reaction [streptozocin results in increased expression of CCN2 protein],,,PMID:21416479,https://www.ncbi.nlm.nih.gov/pubmed/21416479,21416479,,
262,1831231,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Enalapril results in decreased expression of CCN2 mRNA,,,PMID:19349682,https://www.ncbi.nlm.nih.gov/pubmed/19349682,19349682,,
263,1831232,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Enalapril results in decreased expression of CCN2 protein,,,PMID:18812665|PMID:19349682,https://www.ncbi.nlm.nih.gov/pubmed/18812665|https://www.ncbi.nlm.nih.gov/pubmed/19349682,18812665|19349682,,
264,1831233,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,57393,CLTRN,https://ctdbase.org/detail.go?type=gene&acc=57393,,,57393.0,CLTRN,10116.0,Rattus norvegicus (Norway rat),Enalapril results in decreased expression of CLTRN protein|enalapril results in decreased expression of CLTRN mRNA,,,PMID:12887829,https://www.ncbi.nlm.nih.gov/pubmed/12887829,12887829,,
265,1831234,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10116.0,Rattus norvegicus (Norway rat),Enalapril results in decreased expression of CLU protein,,,PMID:12193663,https://www.ncbi.nlm.nih.gov/pubmed/12193663,12193663,,
266,1831235,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1215,CMA1,https://ctdbase.org/detail.go?type=gene&acc=1215,,,1215.0,CMA1,10116.0,Rattus norvegicus (Norway rat),Enalapril results in decreased expression of CMA1 mRNA,,,PMID:18796534,https://www.ncbi.nlm.nih.gov/pubmed/18796534,18796534,,
267,1831236,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Enalapril inhibits the reaction [bleomycin results in increased expression of COL1A1 mrna],,,PMID:12003776,https://www.ncbi.nlm.nih.gov/pubmed/12003776,12003776,,
268,1831715,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,10116.0,Rattus norvegicus (Norway rat),Enalapril inhibits the reaction [streptozocin results in increased expression of EPO mrna],,,PMID:19958114,https://www.ncbi.nlm.nih.gov/pubmed/19958114,19958114,,
269,1831716,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,2057,EPOR,https://ctdbase.org/detail.go?type=gene&acc=2057,,,2057.0,EPOR,10116.0,Rattus norvegicus (Norway rat),Enalapril inhibits the reaction [streptozocin results in increased expression of EPOR protein]|enalapril inhibits the reaction [streptozocin results in increased expression of EPOR mrna],,,PMID:19958114,https://www.ncbi.nlm.nih.gov/pubmed/19958114,19958114,,
270,1831717,5388961,Comparative Toxicogenomics Database (CTD),Enalapril maleate,D004656,Enalapril,https://ctdbase.org/detail.go?type=chem&acc=D004656,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606.0,Homo sapiens (human),Enalapril inhibits the reaction [[shiga toxin 1 co-treated with TNF protein] results in increased activity of F3 protein],,,PMID:18060435,https://www.ncbi.nlm.nih.gov/pubmed/18060435,18060435,,
271,1831825,5403772,BindingDB,,15363,"4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15363,1645,Heat shock protein HSP 90-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1645,P08238,Heat shock protein HSP 90-beta,3326.0,HSP90AB1,9606.0,Homo sapiens (human),,IC50 (nM),4730,PMID:15974572|DOI:10.1021/jm050355z,https://www.ncbi.nlm.nih.gov/pubmed/15974572|https://doi.org/10.1021/jm050355z,15974572,10.1021/jm050355z,
272,1831824,5406463,BindingDB,,24713,"1,2,4,5-tetrahydropyrazolo[3,4-a]carbazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24713,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
273,1830916,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10090.0,Mus musculus (house mouse),Cobalt inhibits the reaction [IGF1 protein results in increased import of calcium]|igf1 protein results in increased import of calcium|tetramethrin inhibits the reaction [IGF1 protein results in increased import of calcium],,,PMID:1550224|PMID:2460452|PMID:2539779,https://www.ncbi.nlm.nih.gov/pubmed/1550224|https://www.ncbi.nlm.nih.gov/pubmed/2460452|https://www.ncbi.nlm.nih.gov/pubmed/2539779,1550224|2460452|2539779,,
274,1830917,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),Calcium affects the expression of IGF1 mRNA,,,PMID:15913539,https://www.ncbi.nlm.nih.gov/pubmed/15913539,15913539,,
275,1830918,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,10090.0,Mus musculus (house mouse),Cobalt inhibits the reaction [IGF2 protein results in increased import of calcium]|tetramethrin inhibits the reaction [IGF2 protein results in increased import of calcium],,,PMID:2442157|PMID:2539779,https://www.ncbi.nlm.nih.gov/pubmed/2442157|https://www.ncbi.nlm.nih.gov/pubmed/2539779,2442157|2539779,,
276,1831227,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3708,ITPR1,https://ctdbase.org/detail.go?type=gene&acc=3708,,,3708.0,ITPR1,9606.0,Homo sapiens (human),ITPR1 protein promotes the reaction [ethanol metabolite results in increased abundance of calcium]|itpr1 protein promotes the reaction [acetaldehyde metabolite results in increased abundance of calcium],,,PMID:17241155,https://www.ncbi.nlm.nih.gov/pubmed/17241155,17241155,,
277,1831228,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3709,ITPR2,https://ctdbase.org/detail.go?type=gene&acc=3709,,,3709.0,ITPR2,10090.0,Mus musculus (house mouse),[adenophostin A results in increased activity of ITPR2 protein] which results in increased transport of calcium|xestospongin C inhibits the reaction [[adenophostin A results in increased activity of ITPR2 protein] which results in increased transport of calcium]|2-aminoethoxydiphenyl borate inhibits the reaction [[adenophostin A results in increased activity of ITPR2 protein] which results in increased transport of calcium],,,PMID:15201137,https://www.ncbi.nlm.nih.gov/pubmed/15201137,15201137,,
278,1831340,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,3710,ITPR3,https://ctdbase.org/detail.go?type=gene&acc=3710,,,3710.0,ITPR3,10116.0,Rattus norvegicus (Norway rat),Calcium affects the expression of ITPR3 protein,,,PMID:10963052,https://www.ncbi.nlm.nih.gov/pubmed/10963052,10963052,,
279,1832393,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10116.0,Rattus norvegicus (Norway rat),Calcium affects the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein],,,PMID:12935885,https://www.ncbi.nlm.nih.gov/pubmed/12935885,12935885,,
280,1832394,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,10090.0,Mus musculus (house mouse),NCF1 protein affects the abundance of calcium,,,PMID:16280459,https://www.ncbi.nlm.nih.gov/pubmed/16280459,16280459,,
281,1831170,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LDLRAP1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
282,1831171,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LEF1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
283,1831172,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,10090.0,Mus musculus (house mouse),Soot results in decreased expression of LEF1 mRNA,,,PMID:22461453,https://www.ncbi.nlm.nih.gov/pubmed/22461453,22461453,,
284,1831173,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10637,LEFTY1,https://ctdbase.org/detail.go?type=gene&acc=10637,,,10637.0,LEFTY1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LEFTY1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
285,1831174,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,114823,LENG8,https://ctdbase.org/detail.go?type=gene&acc=114823,,,114823.0,LENG8,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LENG8 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
286,1831175,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LEPR mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
287,1831176,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),Soot results in decreased expression of LEPR mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
288,1831177,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606.0,Homo sapiens (human),[soot co-treated with benzo(a)pyrene] results in increased expression of LGALS1 protein modified form,,,PMID:24464499,https://www.ncbi.nlm.nih.gov/pubmed/24464499,24464499,,
289,1831178,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of LGALS1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
290,1831331,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3960,LGALS4,https://ctdbase.org/detail.go?type=gene&acc=3960,,,3960.0,LGALS4,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LGALS4 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
291,1831332,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,29094,LGALSL,https://ctdbase.org/detail.go?type=gene&acc=29094,,,29094.0,LGALSL,10090.0,Mus musculus (house mouse),Soot results in increased expression of LGALSL mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
292,1831333,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,55203,LGI2,https://ctdbase.org/detail.go?type=gene&acc=55203,,,55203.0,LGI2,10090.0,Mus musculus (house mouse),Soot results in increased expression of LGI2 mRNA,,,PMID:22461453|PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/22461453|https://www.ncbi.nlm.nih.gov/pubmed/26551751,22461453|26551751,,
293,1831334,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,203190,LGI3,https://ctdbase.org/detail.go?type=gene&acc=203190,,,203190.0,LGI3,10090.0,Mus musculus (house mouse),Soot results in decreased expression of LGI3 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
294,1831335,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of LHFPL2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
295,1831336,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,10090.0,Mus musculus (house mouse),Soot results in increased expression of LHFPL2 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
296,1831337,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LHFPL6 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
297,1831338,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3976,LIF,https://ctdbase.org/detail.go?type=gene&acc=3976,,,3976.0,LIF,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of LIF mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
298,1831339,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LIFR mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
299,1831526,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3978,LIG1,https://ctdbase.org/detail.go?type=gene&acc=3978,,,3978.0,LIG1,10090.0,Mus musculus (house mouse),Soot results in increased expression of LIG1 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
300,1831527,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,353514,LILRA5,https://ctdbase.org/detail.go?type=gene&acc=353514,,,353514.0,LILRA5,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of LILRA5 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of LILRA5 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
301,1831528,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,79168,LILRA6,https://ctdbase.org/detail.go?type=gene&acc=79168,,,79168.0,LILRA6,10090.0,Mus musculus (house mouse),Soot results in increased expression of LILRA6 mRNA,,,PMID:22461453,https://www.ncbi.nlm.nih.gov/pubmed/22461453,22461453,,
302,1831529,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,11006,LILRB4,https://ctdbase.org/detail.go?type=gene&acc=11006,,,11006.0,LILRB4,10090.0,Mus musculus (house mouse),Soot results in increased expression of LILRB4 mRNA,,,PMID:22461453|PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/22461453|https://www.ncbi.nlm.nih.gov/pubmed/26551751,22461453|26551751,,
303,1831530,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,14727,LILRB4B,https://ctdbase.org/detail.go?type=gene&acc=14727,,,14727.0,Lilrb4b,10090.0,Mus musculus (house mouse),Soot results in increased expression of LILRB4B mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
304,1831531,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,55679,LIMS2,https://ctdbase.org/detail.go?type=gene&acc=55679,,,55679.0,LIMS2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of LIMS2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
305,1831532,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,79727,LIN28A,https://ctdbase.org/detail.go?type=gene&acc=79727,,,79727.0,LIN28A,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of LIN28A mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
306,1831533,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,286826,LIN9,https://ctdbase.org/detail.go?type=gene&acc=286826,,,286826.0,LIN9,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of LIN9 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
307,1831534,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,3988,LIPA,https://ctdbase.org/detail.go?type=gene&acc=3988,,,3988.0,LIPA,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of LIPA mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
308,1831830,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,10090.0,Mus musculus (house mouse),Soot results in increased expression of LMNB1 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
309,1831821,5462311,Comparative Toxicogenomics Database (CTD),Boron,D001895,Boron,https://ctdbase.org/detail.go?type=chem&acc=D001895,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Boron inhibits the reaction [dietary fats results in increased expression of TNF mrna],,,PMID:36419211,https://www.ncbi.nlm.nih.gov/pubmed/36419211,36419211,,
310,1831822,5462347,ChEMBL,Hydromorphone Hydrochloride,CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237055/,CHEMBL233,Mu opioid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL233/,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),Mu opioid receptor agonist,,,,,,,
311,1831823,5462350,ChEMBL,Oxycodone Hydrochloride,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200890/,CHEMBL233,Mu opioid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL233/,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),Mu opioid receptor agonist,,,,,,,
312,1831826,5464092,Drug Gene Interaction database (DGIdb),Naloxone Hydrochloride,,NALOXONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203192,,OPRK1,https://www.dgidb.org/genes/hgnc:8154,,,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,,,,,
313,1831827,5464092,Drug Gene Interaction database (DGIdb),Naloxone Hydrochloride,,NALOXONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203192,,BDNF,https://www.dgidb.org/genes/hgnc:1033,,,627.0,BDNF,9606.0,Homo sapiens (human),,,,,,,,
314,1831828,5464105,Therapeutic Target Database (TTD),Nitecapone,D08LVF,Nitecapone,https://idrblab.net/ttd/data/drug/details/D08LVF,T76904,Catechol-O-methyl-transferase (COMT),https://idrblab.net/ttd/data/target/details/T76904,P21964,Catechol O-methyltransferase,1312.0,COMT,9606.0,Homo sapiens (human),Modulator,,,,,,,
315,1831829,5464343,ChEMBL,Imidapril,CHEMBL317094,IMIDAPRIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL317094/,CHEMBL1808,Angiotensin-converting enzyme,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1808/,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606.0,Homo sapiens (human),Angiotensin-converting enzyme inhibitor,,,,,,,
316,1832326,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,1376,CPT2,https://ctdbase.org/detail.go?type=gene&acc=1376,,,1376.0,CPT2,10036.0,Mesocricetus auratus (golden hamster),Zerumbone inhibits the reaction [dietary fats results in decreased expression of CPT2 mrna],,,PMID:24709573,https://www.ncbi.nlm.nih.gov/pubmed/24709573,24709573,,
317,1832327,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Zerumbone results in decreased expression of CYP1A1 mRNA,,,PMID:36122806,https://www.ncbi.nlm.nih.gov/pubmed/36122806,36122806,,
318,1832328,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Zerumbone results in increased expression of CYP1A2 mRNA,,,PMID:36122806,https://www.ncbi.nlm.nih.gov/pubmed/36122806,36122806,,
319,1832329,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),Zerumbone results in increased expression of CYP2C19 mRNA,,,PMID:36122806,https://www.ncbi.nlm.nih.gov/pubmed/36122806,36122806,,
320,1832596,5471349,Drug Gene Interaction database (DGIdb),Bergamottin,,BERGAMOTTIN,https://www.dgidb.org/drugs/chembl:CHEMBL1078442,,BACE1,https://www.dgidb.org/genes/hgnc:933,,,23621.0,BACE1,9606.0,Homo sapiens (human),,,,,,,,
321,1832597,5471349,Drug Gene Interaction database (DGIdb),Bergamottin,,BERGAMOTTIN,https://www.dgidb.org/drugs/chembl:CHEMBL1078442,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
322,1832598,5478796,BindingDB,"6-(4,5-dihydro-1H-imidazol-2-yl)-2-[(E)-2-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]ethenyl]-1H-indole",153318,BPH-1417,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153318,7045,Short-chain Z-isoprenyl diphosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7045,Q7U0P8,Short-chain Z-isoprenyl diphosphate synthase,,,233413.0,Mycobacterium tuberculosis variant bovis AF2122/97,,IC50 (nM),4.8e+3,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
323,1832599,5478796,BindingDB,"6-(4,5-dihydro-1H-imidazol-2-yl)-2-[(E)-2-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]ethenyl]-1H-indole",153318,BPH-1417,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153318,7046,Tuberculosinyl adenosine transferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7046,P9WJ60,Tuberculosinyl adenosine transferase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),6.6e+2,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
324,1832600,5478796,BindingDB,"6-(4,5-dihydro-1H-imidazol-2-yl)-2-[(E)-2-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]ethenyl]-1H-indole",153318,BPH-1417,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153318,7044,Decaprenyl diphosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7044,P9WFF6,Decaprenyl diphosphate synthase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),2.0e+4,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
325,1832601,5478796,BindingDB,"6-(4,5-dihydro-1H-imidazol-2-yl)-2-[(E)-2-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]ethenyl]-1H-indole",153318,BPH-1417,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153318,7044,Decaprenyl diphosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7044,P9WFF6,Decaprenyl diphosphate synthase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),4.9e+2,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
326,1830919,6437068,Drug Gene Interaction database (DGIdb),2-Propyl-2-pentenoic acid,,CHEMBL:CHEMBL117487,https://www.dgidb.org/drugs/chembl:CHEMBL117487,,HDAC5,https://www.dgidb.org/genes/hgnc:14068,,,10014.0,HDAC5,9606.0,Homo sapiens (human),,,,,,,,
327,1830920,6437068,Drug Gene Interaction database (DGIdb),2-Propyl-2-pentenoic acid,,CHEMBL:CHEMBL117487,https://www.dgidb.org/drugs/chembl:CHEMBL117487,,HDAC7,https://www.dgidb.org/genes/hgnc:14067,,,51564.0,HDAC7,9606.0,Homo sapiens (human),,,,,,,,
328,1830921,6437068,Drug Gene Interaction database (DGIdb),2-Propyl-2-pentenoic acid,,CHEMBL:CHEMBL117487,https://www.dgidb.org/drugs/chembl:CHEMBL117487,,HDAC2,https://www.dgidb.org/genes/hgnc:4853,,,3066.0,HDAC2,9606.0,Homo sapiens (human),,,,,,,,
329,1830922,6438142,Comparative Toxicogenomics Database (CTD),Otosenine,C432462,otosenine,https://ctdbase.org/detail.go?type=chem&acc=C432462,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Otosenine results in increased expression of H2AX protein,,,PMID:31154085,https://www.ncbi.nlm.nih.gov/pubmed/31154085,31154085,,
330,1830923,6438331,Comparative Toxicogenomics Database (CTD),Methyl 4-(2-((2-hydroxy-2-phenethyl)amino)propyl)benzoate-2-butanedioate,C039248,BRL 26830A,https://ctdbase.org/detail.go?type=chem&acc=C039248,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,9606.0,Homo sapiens (human),BRL 26830A binds to and results in increased activity of ADRB3 protein,,,PMID:7520314,https://www.ncbi.nlm.nih.gov/pubmed/7520314,7520314,,
331,1830924,6438354,BindingDB,N-(3-phenoxycinnamyl)acetohydroxamic acid,22334,BW A4C,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22334,2263,Lipoxygenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2263,,,,,,,,IC50 (nM),1.71e+4,PMID:27943581|DOI:10.1002/cbic.201600636,https://www.ncbi.nlm.nih.gov/pubmed/27943581|https://doi.org/10.1002/cbic.201600636,27943581,10.1002/cbic.201600636,
332,1830925,6439089,Drug Gene Interaction database (DGIdb),"(E)-4-(1,2,3,6-Tetrahydro-2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)cinnamic acid",,SKF-83959,https://www.dgidb.org/drugs/iuphar.ligand:8443,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
333,1832770,6483688,BindingDB,(3S)-3-carbamoyl-3-(2-{3-[(2S)-2-[(2S)-2-cyclohexyl-2-{[(2-methylpropoxy)carbonyl]amino}acetamido]-4-methylpentanamido]-2-oxohexanamido}acetamido)propanoic acid,9721,(3S)-3-carbamoyl-3-(2-{3-[(2S)-2-[(2S)-2-cyclohexyl-2-{[(2-methylpropoxy)carbonyl]amino}acetamido]-4-methylpentanamido]-2-oxohexanamido}acetamido)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9721,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),8400,PMID:16087332|DOI:10.1016/j.bmcl.2005.06.091,https://www.ncbi.nlm.nih.gov/pubmed/16087332|https://doi.org/10.1016/j.bmcl.2005.06.091,16087332,10.1016/j.bmcl.2005.06.091,
334,1831007,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,374918,IGFL1,https://ctdbase.org/detail.go?type=gene&acc=374918,,,374918.0,IGFL1,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGFL1 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
335,1831008,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,147920,IGFL2,https://ctdbase.org/detail.go?type=gene&acc=147920,,,147920.0,IGFL2,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGFL2 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
336,1831009,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,388555,IGFL3,https://ctdbase.org/detail.go?type=gene&acc=388555,,,388555.0,IGFL3,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGFL3 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
337,1831010,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,79713,IGFLR1,https://ctdbase.org/detail.go?type=gene&acc=79713,,,79713.0,IGFLR1,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGFLR1 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
338,1831011,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,3492,IGH,https://ctdbase.org/detail.go?type=gene&acc=3492,,,3492.0,IGH,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGH gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
339,1831012,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,3493,IGHA1,https://ctdbase.org/detail.go?type=gene&acc=3493,,,3493.0,IGHA1,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IGHA1 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
340,1832884,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,10526,IPO8,https://ctdbase.org/detail.go?type=gene&acc=10526,,,10526.0,IPO8,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IPO8 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
341,1832885,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,55705,IPO9,https://ctdbase.org/detail.go?type=gene&acc=55705,,,55705.0,IPO9,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IPO9 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
342,1832886,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,3652,IPP,https://ctdbase.org/detail.go?type=gene&acc=3652,,,3652.0,IPP,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IPP gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
343,1832887,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,79781,IQCA1,https://ctdbase.org/detail.go?type=gene&acc=79781,,,79781.0,IQCA1,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IQCA1 gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
344,1832888,6509863,Comparative Toxicogenomics Database (CTD),"1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea",C092451,CGP 52608,https://ctdbase.org/detail.go?type=chem&acc=C092451,64799,IQCH,https://ctdbase.org/detail.go?type=gene&acc=64799,,,64799.0,IQCH,9606.0,Homo sapiens (human),CGP 52608 promotes the reaction [RORA protein binds to IQCH gene],,,PMID:28238834,https://www.ncbi.nlm.nih.gov/pubmed/28238834,28238834,,
345,1831384,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,55968,NSFL1C,https://ctdbase.org/detail.go?type=gene&acc=55968,,,55968.0,NSFL1C,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of NSFL1C mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
346,1831385,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,8439,NSMAF,https://ctdbase.org/detail.go?type=gene&acc=8439,,,8439.0,NSMAF,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of NSMAF mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
347,1831386,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,197370,NSMCE1,https://ctdbase.org/detail.go?type=gene&acc=197370,,,197370.0,NSMCE1,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of NSMCE1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
348,1831387,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,286053,NSMCE2,https://ctdbase.org/detail.go?type=gene&acc=286053,,,286053.0,NSMCE2,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of NSMCE2 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
349,1831388,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,54780,NSMCE4A,https://ctdbase.org/detail.go?type=gene&acc=54780,,,54780.0,NSMCE4A,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of NSMCE4A mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
350,1831389,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,63899,NSUN3,https://ctdbase.org/detail.go?type=gene&acc=63899,,,63899.0,NSUN3,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of NSUN3 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
351,1831282,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,126661,CCDC163,https://ctdbase.org/detail.go?type=gene&acc=126661,,,126661.0,CCDC163,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of CCDC163 mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817,,
352,1831283,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,51244,CCDC174,https://ctdbase.org/detail.go?type=gene&acc=51244,,,51244.0,CCDC174,10090.0,Mus musculus (house mouse),Particulate matter results in increased expression of CCDC174 mRNA,,,PMID:36857595,https://www.ncbi.nlm.nih.gov/pubmed/36857595,36857595,,
353,1831284,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,56936,CCDC177,https://ctdbase.org/detail.go?type=gene&acc=56936,,,56936.0,CCDC177,10090.0,Mus musculus (house mouse),Particulate matter results in decreased methylation of CCDC177 gene,,,PMID:28495853,https://www.ncbi.nlm.nih.gov/pubmed/28495853,28495853,,
354,1831285,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,100499483,CCDC180,https://ctdbase.org/detail.go?type=gene&acc=100499483,,,100499483.0,CCDC180,10116.0,Rattus norvegicus (Norway rat),[oxygen deficiency co-treated with blood glucose deficiency co-treated with particulate matter] results in increased expression of CCDC180 mRNA,,,PMID:33729688,https://www.ncbi.nlm.nih.gov/pubmed/33729688,33729688,,
355,1831286,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,339512,CCDC190,https://ctdbase.org/detail.go?type=gene&acc=339512,,,339512.0,CCDC190,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of CCDC190 mRNA,,,PMID:32579111,https://www.ncbi.nlm.nih.gov/pubmed/32579111,32579111,,
356,1831287,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,57577,CCDC191,https://ctdbase.org/detail.go?type=gene&acc=57577,,,57577.0,CCDC191,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of CCDC191 mRNA,,,PMID:29883952,https://www.ncbi.nlm.nih.gov/pubmed/29883952,29883952,,
357,1831288,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,149473,CCDC24,https://ctdbase.org/detail.go?type=gene&acc=149473,,,149473.0,CCDC24,9606.0,Homo sapiens (human),[[gasoline co-treated with ethanol] results in increased abundance of [particulate matter co-treated with polycyclic aromatic hydrocarbons]] which results in increased expression of CCDC24 mRNA,,,PMID:29432896,https://www.ncbi.nlm.nih.gov/pubmed/29432896,29432896,,
358,1831289,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,55246,CCDC25,https://ctdbase.org/detail.go?type=gene&acc=55246,,,55246.0,CCDC25,9606.0,Homo sapiens (human),Particulate matter results in increased expression of CCDC25 mrna|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [particulate matter results in increased expression of CCDC25 mrna],,,PMID:28655636,https://www.ncbi.nlm.nih.gov/pubmed/28655636,28655636,,
359,1831951,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,388115,CCDC9B,https://ctdbase.org/detail.go?type=gene&acc=388115,,,388115.0,CCDC9B,10116.0,Rattus norvegicus (Norway rat),[air pollutants results in increased abundance of particulate matter] which results in decreased expression of CCDC9B mRNA,,,PMID:28106813,https://www.ncbi.nlm.nih.gov/pubmed/28106813,28106813,,
360,1831952,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,9606.0,Homo sapiens (human),Particulate matter analog results in increased expression of CCL1 protein,,,PMID:28101945,https://www.ncbi.nlm.nih.gov/pubmed/28101945,28101945,,
361,1831953,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in decreased expression of CCL1 mRNA,,,PMID:29621558,https://www.ncbi.nlm.nih.gov/pubmed/29621558,29621558,,
362,1831954,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,9606.0,Homo sapiens (human),[particulate matter co-treated with IL13 protein] results in increased expression of CCL11 protein|prolinedithiocarbamate inhibits the reaction [particulate matter results in increased expression of CCL11 protein]|acetylcysteine inhibits the reaction [particulate matter results in increased expression of CCL11 protein]|prolinedithiocarbamate inhibits the reaction [particulate matter results in increased expression of CCL11 mrna]|acetylcysteine inhibits the reaction [particulate matter results in increased expression of CCL11 mrna],,,PMID:12576300,https://www.ncbi.nlm.nih.gov/pubmed/12576300,12576300,,
363,1832255,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),[[air pollutants results in increased abundance of particulate matter] co-treated with [TNF protein co-treated with IFNG protein]] results in increased secretion of CCL2 protein|[air pollutants results in increased abundance of particulate matter] which results in increased secretion of CCL2 protein,,,PMID:32487172,https://www.ncbi.nlm.nih.gov/pubmed/32487172,32487172,,
364,1832256,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of particulate matter] which results in increased expression of CCL2 mRNA,,,PMID:25847963,https://www.ncbi.nlm.nih.gov/pubmed/25847963,25847963,,
365,1832257,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),MIR6515 mRNA inhibits the reaction [particulate matter results in increased expression of CCL2 mrna]|csf3 mRNA promotes the reaction [particulate matter results in increased expression of CCL2 mrna],,,PMID:35798096,https://www.ncbi.nlm.nih.gov/pubmed/35798096,35798096,,
366,1832258,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter analog results in decreased expression of CCL2 mRNA,,,PMID:10359894|PMID:10919993,https://www.ncbi.nlm.nih.gov/pubmed/10359894|https://www.ncbi.nlm.nih.gov/pubmed/10919993,10359894|10919993,,
367,1832259,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter analog results in decreased secretion of CCL2 protein,,,PMID:10359894|PMID:10919993|PMID:20026096,https://www.ncbi.nlm.nih.gov/pubmed/10359894|https://www.ncbi.nlm.nih.gov/pubmed/10919993|https://www.ncbi.nlm.nih.gov/pubmed/20026096,10359894|10919993|20026096,,
368,1832260,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of CCL2 mRNA,,,PMID:32891722,https://www.ncbi.nlm.nih.gov/pubmed/32891722,32891722,,
369,1832261,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of CCL2 protein,,,PMID:28189646,https://www.ncbi.nlm.nih.gov/pubmed/28189646,28189646,,
370,1832262,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,9606.0,Homo sapiens (human),Particulate matter results in increased expression of CCL3 protein,,,PMID:11027454,https://www.ncbi.nlm.nih.gov/pubmed/11027454,11027454,,
371,1832263,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter results in increased expression of CCL2 mRNA,,,PMID:17450221|PMID:20307321|PMID:21652769|PMID:22178795|PMID:25858758|PMID:35798096,https://www.ncbi.nlm.nih.gov/pubmed/17450221|https://www.ncbi.nlm.nih.gov/pubmed/20307321|https://www.ncbi.nlm.nih.gov/pubmed/21652769|https://www.ncbi.nlm.nih.gov/pubmed/22178795|https://www.ncbi.nlm.nih.gov/pubmed/25858758|https://www.ncbi.nlm.nih.gov/pubmed/35798096,17450221|20307321|21652769|22178795|25858758|35798096,,
372,1832395,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Particulate matter results in increased secretion of CCL2 protein,,,PMID:17618502|PMID:20801209|PMID:21652769,https://www.ncbi.nlm.nih.gov/pubmed/17618502|https://www.ncbi.nlm.nih.gov/pubmed/20801209|https://www.ncbi.nlm.nih.gov/pubmed/21652769,17618502|20801209|21652769,,
373,1832396,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Polymyxin B inhibits the reaction [particulate matter results in increased expression of CCL2 mrna]|resveratrol inhibits the reaction [particulate matter results in increased expression of CCL2 mrna],,,PMID:21652769,https://www.ncbi.nlm.nih.gov/pubmed/21652769,21652769,,
374,1832397,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),[tobacco smoke pollution co-treated with particulate matter] results in increased expression of CCL2 mrna|sulforaphane metabolite inhibits the reaction [[tobacco smoke pollution co-treated with particulate matter] results in increased expression of CCL2 mrna]|sulforaphane inhibits the reaction [[tobacco smoke pollution co-treated with particulate matter] results in increased expression of CCL2 mrna],,,PMID:32387680,https://www.ncbi.nlm.nih.gov/pubmed/32387680,32387680,,
375,1832398,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of CCL2 mRNA,,,PMID:28013216,https://www.ncbi.nlm.nih.gov/pubmed/28013216,28013216,,
376,1832399,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Polymyxin B inhibits the reaction [particulate matter results in increased expression of CCL2 mrna]|acetylcysteine inhibits the reaction [particulate matter results in increased expression of CCL2 mrna]|polymyxin B promotes the reaction [acetylcysteine inhibits the reaction [particulate matter results in increased expression of CCL2 mrna]]|myd88 protein affects the reaction [particulate matter results in increased secretion of CCL2 protein]|polymyxin B promotes the reaction [acetylcysteine inhibits the reaction [particulate matter results in increased secretion of CCL2 protein]]|acetylcysteine inhibits the reaction [particulate matter results in increased secretion of CCL2 protein]|polymyxin B inhibits the reaction [particulate matter results in increased secretion of CCL2 protein],,,PMID:28555929,https://www.ncbi.nlm.nih.gov/pubmed/28555929,28555929,,
377,1832400,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),N-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine inhibits the reaction [[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the expression of CCL2 protein]|n-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine inhibits the reaction [[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the expression of CCL2 mrna]|[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the expression of CCL2 protein|[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the expression of CCL2 mRNA,,,PMID:34673409,https://www.ncbi.nlm.nih.gov/pubmed/34673409,34673409,,
378,1832401,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of CCL2 mRNA,,,PMID:30682754,https://www.ncbi.nlm.nih.gov/pubmed/30682754,30682754,,
379,1831003,10111831,IUPHAR/BPS Guide to PHARMACOLOGY,Ono-AE3-208,1942,ONO-AE3-208,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1942,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,P30557,Prostaglandin E2 receptor EP3 subtype,,,10090.0,Mus musculus (house mouse),Antagonist,pKi,7.52,PMID:11927615,https://www.ncbi.nlm.nih.gov/pubmed/11927615,11927615,,
380,1831004,10111831,IUPHAR/BPS Guide to PHARMACOLOGY,Ono-AE3-208,1942,ONO-AE3-208,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1942,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,,,19218.0,Ptger3,10090.0,Mus musculus (house mouse),Antagonist,pKi,7.52,PMID:11927615,https://www.ncbi.nlm.nih.gov/pubmed/11927615,11927615,,
381,1831005,10114664,BindingDB,4-({[4-chloro-2-(4-chlorophenyl)phenyl]methoxy}(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,13376,4-({[4-chloro-2-(4-chlorophenyl)phenyl]methoxy}(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13376,1383,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1383,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2339.0,FNTA,9606.0,Homo sapiens (human),,IC50 (nM),4.8,PMID:14736242|DOI:10.1021/jm030434f,https://www.ncbi.nlm.nih.gov/pubmed/14736242|https://doi.org/10.1021/jm030434f,14736242,10.1021/jm030434f,
382,1831006,10114664,BindingDB,4-({[4-chloro-2-(4-chlorophenyl)phenyl]methoxy}(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,13376,4-({[4-chloro-2-(4-chlorophenyl)phenyl]methoxy}(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13376,1380,Geranylgeranyl transferase type-1 subunit beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1380,Q5EAD5,Geranylgeranyl transferase type-1 subunit beta,509322.0,PGGT1B,9913.0,Bos taurus (cattle),,IC50 (nM),>1000,PMID:14736242|DOI:10.1021/jm030434f,https://www.ncbi.nlm.nih.gov/pubmed/14736242|https://doi.org/10.1021/jm030434f,14736242,10.1021/jm030434f,
383,1966004,10904076,BindingDB,,14331,"2-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-6-bromo-4-methylbenzen-1-olate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14331,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),170,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
384,1966021,10909908,DrugBank,L-Methionine (S)-S-oxide,DB02467,L-methionine (S)-S-oxide,https://www.drugbank.ca/drugs/DB02467,BE0002747,Aminopeptidase S,https://www.drugbank.ca/bio_entities/BE0002747,P80561,Aminopeptidase S,6210128.0,SGR_RS28980,455632.0,Streptomyces griseus subsp. griseus NBRC 13350,,,,,,,,
385,1966022,10913447,BindingDB,"3,3-dimethyl-1-[(2S)-2-pentanoylpiperidin-1-yl]pentane-1,2-dione",23328,"3,3-dimethyl-1-[(2S)-2-pentanoylpiperidin-1-yl]pentane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23328,2390,Peptidyl-prolyl cis-trans isomerase FKBP1A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2390,P18203,Peptidyl-prolyl cis-trans isomerase FKBP1A,614795.0,FKBP1A,9913.0,Bos taurus (cattle),,Ki (nM),3400,PMID:12139467|DOI:10.1021/jm0200456,https://www.ncbi.nlm.nih.gov/pubmed/12139467|https://doi.org/10.1021/jm0200456,12139467,10.1021/jm0200456,
386,1966005,10915062,BindingDB,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea,50115216,"1-(1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl)-3-phenylurea, 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50115216,3933,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3933,P00523,Proto-oncogene tyrosine-protein kinase Src,396442.0,SRC,9031.0,Gallus gallus (chicken),,,,PMID:19396179|DOI:10.1038/nchembio.162,https://www.ncbi.nlm.nih.gov/pubmed/19396179|https://doi.org/10.1038/nchembio.162,19396179,10.1038/nchembio.162,
387,1966006,10915062,BindingDB,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea,50115216,"1-(1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl)-3-phenylurea, 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50115216,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,,,PMID:19396179|DOI:10.1038/nchembio.162,https://www.ncbi.nlm.nih.gov/pubmed/19396179|https://doi.org/10.1038/nchembio.162,19396179,10.1038/nchembio.162,
388,1966007,10918703,IUPHAR/BPS Guide to PHARMACOLOGY,"(S)-3-((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamido)-3-(1H-benzo[d]imidazol-2-yl)propanoic acid",9006,UFP-512,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9006,319,μ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=319,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),Agonist,pKi,8,PMID:18069089,https://www.ncbi.nlm.nih.gov/pubmed/18069089,18069089,,
389,1966008,10918703,IUPHAR/BPS Guide to PHARMACOLOGY,"(S)-3-((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamido)-3-(1H-benzo[d]imidazol-2-yl)propanoic acid",9006,UFP-512,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9006,317,δ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=317,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),Agonist,pKi,10.2,PMID:18069089,https://www.ncbi.nlm.nih.gov/pubmed/18069089,18069089,,
390,1966009,10918703,IUPHAR/BPS Guide to PHARMACOLOGY,"(S)-3-((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamido)-3-(1H-benzo[d]imidazol-2-yl)propanoic acid",9006,UFP-512,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9006,318,κ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),Agonist,pKi,6.66,PMID:18069089,https://www.ncbi.nlm.nih.gov/pubmed/18069089,18069089,,
391,1966010,10932611,Therapeutic Target Database (TTD),3-Fluoro-4-hydrazino-benzenesulfonamide,D01YHK,3-Fluoro-4-hydrazino-benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D01YHK,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
392,1966011,10932611,Therapeutic Target Database (TTD),3-Fluoro-4-hydrazino-benzenesulfonamide,D01YHK,3-Fluoro-4-hydrazino-benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D01YHK,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
393,1966012,10932611,Therapeutic Target Database (TTD),3-Fluoro-4-hydrazino-benzenesulfonamide,D01YHK,3-Fluoro-4-hydrazino-benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D01YHK,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
394,1966057,10935867,BindingDB,"3-Oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",14176,"3-oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14176,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,IC50 (nM),270,PMID:17266195|DOI:10.1021/jm051074u,https://www.ncbi.nlm.nih.gov/pubmed/17266195|https://doi.org/10.1021/jm051074u,17266195,10.1021/jm051074u,
395,1966058,10935867,BindingDB,"3-Oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",14176,"3-oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14176,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,IC50 (nM),308,PMID:17266195|DOI:10.1021/jm051074u,https://www.ncbi.nlm.nih.gov/pubmed/17266195|https://doi.org/10.1021/jm051074u,17266195,10.1021/jm051074u,
396,1966023,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T89361,Cyclin-dependent kinase 6 (CDK6),https://idrblab.net/ttd/data/target/details/T89361,Q00534,Cyclin-dependent kinase 6,1021.0,CDK6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
397,1966024,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T10052,G1/S-specific cyclin-E1 (CCNE1),https://idrblab.net/ttd/data/target/details/T10052,P24864,G1/S-specific cyclin-E1,898.0,CCNE1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
398,1966025,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T49898,Cyclin-dependent kinase 1 (CDK1),https://idrblab.net/ttd/data/target/details/T49898,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
399,1966026,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T12355,G1/S-specific cyclin-D1 (CCND1),https://idrblab.net/ttd/data/target/details/T12355,P24385,G1/S-specific cyclin-D1,595.0,CCND1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
400,1966027,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T47107,Protein kinase C gamma (PRKCG),https://idrblab.net/ttd/data/target/details/T47107,P05129,Protein kinase C gamma type,5582.0,PRKCG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
401,1966028,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
402,1966029,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T12808,Protein kinase C alpha (PRKCA),https://idrblab.net/ttd/data/target/details/T12808,P17252,Protein kinase C alpha type,5578.0,PRKCA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
403,1966030,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T92144,Angiopoietin 1 receptor (TEK),https://idrblab.net/ttd/data/target/details/T92144,Q02763,Angiopoietin-1 receptor,7010.0,TEK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
404,1966048,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T85799,Cyclin-dependent kinase 4 (CDK4),https://idrblab.net/ttd/data/target/details/T85799,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
405,1966049,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T70176,Cyclin-dependent kinase 2 (CDK2),https://idrblab.net/ttd/data/target/details/T70176,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
406,1966050,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T59328,Epidermal growth factor receptor (EGFR),https://idrblab.net/ttd/data/target/details/T59328,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
407,1966051,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T98459,G2/mitotic-specific cyclin B1 (CCNB1),https://idrblab.net/ttd/data/target/details/T98459,P14635,G2/mitotic-specific cyclin-B1,891.0,CCNB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
408,1966052,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T96788,ERBB2 messenger RNA (HER2 mRNA),https://idrblab.net/ttd/data/target/details/T96788,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
409,1966053,10946795,Therapeutic Target Database (TTD),"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",https://idrblab.net/ttd/data/drug/details/D00NYT,T00895,Protein kinase C epsilon (PRKCE),https://idrblab.net/ttd/data/target/details/T00895,Q02156,Protein kinase C epsilon type,5581.0,PRKCE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
410,1966059,10963509,Drug Gene Interaction database (DGIdb),Pipertramine,,PIPERTRAMINE,https://www.dgidb.org/drugs/chembl:CHEMBL127273,,CHRM3,https://www.dgidb.org/genes/hgnc:1952,,,1131.0,CHRM3,9606.0,Homo sapiens (human),,,,,,,,
411,1966060,10963509,Drug Gene Interaction database (DGIdb),Pipertramine,,PIPERTRAMINE,https://www.dgidb.org/drugs/chembl:CHEMBL127273,,CHRM5,https://www.dgidb.org/genes/hgnc:1954,,,1133.0,CHRM5,9606.0,Homo sapiens (human),,,,,,,,
412,1966061,10963571,Drug Gene Interaction database (DGIdb),Cypate,,CYPATE,https://www.dgidb.org/drugs/chembl:CHEMBL2071606,,ITGAV,https://www.dgidb.org/genes/hgnc:6150,,,3685.0,ITGAV,9606.0,Homo sapiens (human),,,,,,,,
413,1966062,10967421,Therapeutic Target Database (TTD),Octanedioic acid hydroxyamide pyridin-4-ylamide,D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,https://idrblab.net/ttd/data/drug/details/D04GGW,T94324,Histone deacetylase 10 (HDAC10),https://idrblab.net/ttd/data/target/details/T94324,Q969S8,Polyamine deacetylase HDAC10,83933.0,HDAC10,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
414,1966063,10967421,Therapeutic Target Database (TTD),Octanedioic acid hydroxyamide pyridin-4-ylamide,D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,https://idrblab.net/ttd/data/drug/details/D04GGW,T51191,Histone deacetylase 2 (HDAC2),https://idrblab.net/ttd/data/target/details/T51191,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
415,1966064,10967421,Therapeutic Target Database (TTD),Octanedioic acid hydroxyamide pyridin-4-ylamide,D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,https://idrblab.net/ttd/data/drug/details/D04GGW,T28887,Histone deacetylase 8 (HDAC8),https://idrblab.net/ttd/data/target/details/T28887,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
416,1966065,10967421,Therapeutic Target Database (TTD),Octanedioic acid hydroxyamide pyridin-4-ylamide,D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,https://idrblab.net/ttd/data/drug/details/D04GGW,T63816,Histone deacetylase 4 (HDAC4),https://idrblab.net/ttd/data/target/details/T63816,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
417,1966066,10967421,Therapeutic Target Database (TTD),Octanedioic acid hydroxyamide pyridin-4-ylamide,D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,https://idrblab.net/ttd/data/drug/details/D04GGW,T22274,Histone deacetylase 6 (HDAC6),https://idrblab.net/ttd/data/target/details/T22274,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
418,1966054,10968945,BindingDB,"Benzofuran, 23",16457,"6-[(5-chloro-1-benzofuran-2-)sulfonyl]-2,3-dihydropyridazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16457,8450,Aldo-keto reductase family 1 member B1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8450,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:16190759|DOI:10.1021/jm050462t,https://www.ncbi.nlm.nih.gov/pubmed/16190759|https://doi.org/10.1021/jm050462t,16190759,10.1021/jm050462t,
419,1966055,10968945,BindingDB,"Benzofuran, 23",16457,"6-[(5-chloro-1-benzofuran-2-)sulfonyl]-2,3-dihydropyridazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16457,8450,Aldo-keto reductase family 1 member B1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8450,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:12773033|DOI:10.1021/jm034065z,https://www.ncbi.nlm.nih.gov/pubmed/12773033|https://doi.org/10.1021/jm034065z,12773033,10.1021/jm034065z,
420,1966056,10970100,BindingDB,(2S)-2-amino-N-(1-diphenoxyphosphorylethyl)propanamide,98051,(2S)-2-amino-N-(1-diphenoxyphosphorylethyl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=98051,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),<1000000,PMID:12739951|DOI:10.1021/cc020096o,https://www.ncbi.nlm.nih.gov/pubmed/12739951|https://doi.org/10.1021/cc020096o,12739951,10.1021/cc020096o,
421,1966076,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0001385,Protein kinase C theta type,https://www.drugbank.ca/bio_entities/BE0001385,Q04759,Protein kinase C theta type,5588.0,PRKCQ,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
422,1966077,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0000991,Aurora kinase A,https://www.drugbank.ca/bio_entities/BE0000991,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
423,1966078,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0000923,Mitogen-activated protein kinase 1,https://www.drugbank.ca/bio_entities/BE0000923,P28482,Mitogen-activated protein kinase 1,5594.0,MAPK1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
424,1966079,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,https://www.drugbank.ca/bio_entities/BE0003761,P17612,cAMP-dependent protein kinase catalytic subunit alpha,5566.0,PRKACA,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
425,1966080,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0004475,cAMP-dependent protein kinase catalytic subunit beta,https://www.drugbank.ca/bio_entities/BE0004475,P22694,cAMP-dependent protein kinase catalytic subunit beta,5567.0,PRKACB,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
426,1966081,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0001913,Cyclin-dependent kinase 7,https://www.drugbank.ca/bio_entities/BE0001913,P50613,Cyclin-dependent kinase 7,1022.0,CDK7,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
427,1966082,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0001652,Threonine-phosphate decarboxylase,https://www.drugbank.ca/bio_entities/BE0001652,P97084,Threonine-phosphate decarboxylase,1252164.0,cobD,99287.0,Salmonella enterica subsp. enterica serovar Typhimurium str. LT2,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
428,1966083,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0001200,Rhodopsin,https://www.drugbank.ca/bio_entities/BE0001200,P08100,Rhodopsin,6010.0,RHO,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
429,1966084,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0002789,Protein S100-A11,https://www.drugbank.ca/bio_entities/BE0002789,P31949,Protein S100-A11,6282.0,S100A11,9606.0,Homo sapiens (human),,,,,,,,
430,1966085,10976469,DrugBank,Phosphonothreonine,DB02482,Phosphonothreonine,https://www.drugbank.ca/drugs/DB02482,BE0002790,Mitogen-activated protein kinase 12,https://www.drugbank.ca/bio_entities/BE0002790,P53778,Mitogen-activated protein kinase 12,6300.0,MAPK12,9606.0,Homo sapiens (human),,,,,,,,
431,1965996,11356920,BindingDB,"2H-1-Benzopyran-2-thione, 6-(1H-imidazol-1-ylmethyl)-",9486,6-(1H-Imidazol-1-ylmethyl)-2H-chrome-2-thione,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9486,1039,"Steroid 17-alpha-hydroxylase/17,20 lyase",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1039,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",1586.0,CYP17A1,9606.0,Homo sapiens (human),,,,PMID:15615528|DOI:10.1021/jm049535j,https://www.ncbi.nlm.nih.gov/pubmed/15615528|https://doi.org/10.1021/jm049535j,15615528,10.1021/jm049535j,
432,1965997,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0000817,Glutathione peroxidase 2,http://www.t3db.ca/biodb/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
433,1965998,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0000821,Glutathione peroxidase 3,http://www.t3db.ca/biodb/bio_entities/BE0000821,P22352,Glutathione peroxidase 3,2878.0,GPX3,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
434,1965999,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002286,Glutathione peroxidase 6,http://www.t3db.ca/biodb/bio_entities/BE0002286,P59796,Glutathione peroxidase 6,257202.0,GPX6,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
435,1966000,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882.0,GPX7,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
436,1966001,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
437,1966002,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
438,1966003,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
439,1966031,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
440,1966032,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
441,1966033,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
442,1966034,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002254,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",6390.0,SDHB,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
443,1966035,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
444,1966036,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
445,1966037,11378442,Toxin and Toxin Target Database (T3DB),Potassium cyanate,T3D0776,Potassium cyanate,http://www.t3db.ca/toxins/T3D0776,BE0000252,Tyrosinase,http://www.t3db.ca/biodb/bio_entities/BE0000252,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Cyanide inhibits tyrosinase. (A77),,,PMID:16950829,https://www.ncbi.nlm.nih.gov/pubmed/16950829,16950829,,
446,1966038,11381309,BindingDB,"1H-1,2,3-Triazole, 1-(9-phenyl-9H-fluoren-9-yl)-",9467,"1-(9-Phenyl-9H-fluoren-9-yl)-1H-1,2,3-triazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9467,1039,"Steroid 17-alpha-hydroxylase/17,20 lyase",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1039,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",1586.0,CYP17A1,9606.0,Homo sapiens (human),,,,PMID:15615528|DOI:10.1021/jm049535j,https://www.ncbi.nlm.nih.gov/pubmed/15615528|https://doi.org/10.1021/jm049535j,15615528,10.1021/jm049535j,
447,1966020,11418781,BindingDB,"(2S)-1-{[(2S,5R)-5-{[(6-bromo-2H-1,3-benzodioxol-5-yl)oxy]methyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carbonitrile",11108,"(2S)-1-{[(2S,5R)-5-{[(6-bromo-2H-1,3-benzodioxol-5-yl)oxy]methyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11108,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),0.41,PMID:16759095|DOI:10.1021/jm051283e,https://www.ncbi.nlm.nih.gov/pubmed/16759095|https://doi.org/10.1021/jm051283e,16759095,10.1021/jm051283e,
448,1966019,11430541,BindingDB,3-[(4-Tert-butylphenyl)methyl]-1-[1-(3-fluoro-4-methanesulfonamidophenyl)ethyl]thiourea,20322,3-[(4-tert-butylphenyl)methyl]-1-[1-(3-fluoro-4-methanesulfonamidophenyl)ethyl]thiourea,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20322,2071,Transient receptor potential cation channel subfamily V member 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2071,O35433,Transient receptor potential cation channel subfamily V member 1,83810.0,Trpv1,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),54,PMID:17629487|DOI:10.1016/j.bmc.2007.06.041,https://www.ncbi.nlm.nih.gov/pubmed/17629487|https://doi.org/10.1016/j.bmc.2007.06.041,17629487,10.1016/j.bmc.2007.06.041,
449,1966039,11440448,Therapeutic Target Database (TTD),2-[4-Hydroxy-1-methyl-7-(4-methoxy-phenoxy)-isoquinoline-3-carboxamido]acetic acid,D0LO2C,"US9340511, 5",https://idrblab.net/ttd/data/drug/details/D0LO2C,T32880,HIF-prolyl hydroxylase 2 (HPH-2),https://idrblab.net/ttd/data/target/details/T32880,Q9GZT9,Egl nine homolog 1,54583.0,EGLN1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
450,1966013,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7T3,30S ribosomal protein S16,944960.0,ykgM,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
451,1966014,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7T7,30S ribosomal protein S18,945657.0,rpmF,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
452,1966015,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7U3,30S ribosomal protein S19,84236347.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
453,1966016,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7U7,30S ribosomal protein S20,946318.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
454,1966017,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V0,30S ribosomal protein S2,8913847.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
455,1966018,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V3,30S ribosomal protein S3,948216.0,rpmH,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
456,1966040,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V8,30S ribosomal protein S4,84238873.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
457,1966041,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W1,30S ribosomal protein S5,946349.0,rpmI,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
458,1966042,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W7,30S ribosomal protein S8,84236820.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
459,1966043,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7X3,30S ribosomal protein S9,947805.0,rpmJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
460,1966044,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AA10,50S ribosomal protein L13,84234858.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
461,1966045,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY3,50S ribosomal protein L14,947816.0,rpsJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
462,1966046,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY7,50S ribosomal protein L16,83578291.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
463,1966047,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADZ0,50S ribosomal protein L23,947792.0,rpsK,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
464,1966067,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADZ4,30S ribosomal protein S15,84234860.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
465,1966068,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG44,50S ribosomal protein L17,947845.0,rpsL,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
466,1966069,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG48,50S ribosomal protein L21,84234829.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
467,1966070,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG51,50S ribosomal protein L30,947791.0,rpsM,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
468,1966071,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG55,50S ribosomal protein L6,83578268.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
469,1966072,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG59,30S ribosomal protein S14,947103.0,rpsP,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
470,1966073,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG63,30S ribosomal protein S17,83579843.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
471,1966074,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG67,30S ribosomal protein S1,948721.0,rpsR,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
472,1966075,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0C018,50S ribosomal protein L18,9735149.0,rpsR,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
473,1966086,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60422,50S ribosomal protein L2,947811.0,rpsS,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
474,1966087,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60438,50S ribosomal protein L3,84234841.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
475,1966088,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60624,50S ribosomal protein L24,944759.0,rpsT,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
476,1966089,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60723,50S ribosomal protein L4,83578037.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
477,1966090,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P61175,50S ribosomal protein L22,947874.0,rpsB,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
478,1966091,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P62399,50S ribosomal protein L5,83577893.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
479,1966092,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68679,30S ribosomal protein S21,947814.0,rpsC,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
480,1966093,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68919,50S ribosomal protein L25,84234843.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
481,1966094,11476460,ChEMBL,Tedizolid Phosphate,CHEMBL2105669,TEDIZOLID PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105669/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,Q2EEQ2,50S ribosomal protein L36 2,947793.0,rpsD,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:18838596|PMID:25673021,https://www.ncbi.nlm.nih.gov/pubmed/18838596|https://www.ncbi.nlm.nih.gov/pubmed/25673021,18838596|25673021,,
482,1966095,21302490,ChEMBL,Lumateperone,CHEMBL3306803,LUMATEPERONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3306803/,CHEMBL228,Serotonin transporter,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL228/,P31645,Sodium-dependent serotonin transporter,6532.0,SLC6A4,9606.0,Homo sapiens (human),Serotonin transporter inhibitor,,,PMID:24559051|PMID:25120104,https://www.ncbi.nlm.nih.gov/pubmed/24559051|https://www.ncbi.nlm.nih.gov/pubmed/25120104,24559051|25120104,,
483,1966096,21466113,BindingDB,"4,6-Dimethoxypyrimidine-2-carbonitrile",496398,AAR-RCN-748c104b-1,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496398,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99000,,,,,
484,1966097,21496278,Therapeutic Target Database (TTD),2-(2-(Biphenyl-4-yl)ethylsulfinyl)acetic acid,D0F4UT,2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid,https://idrblab.net/ttd/data/drug/details/D0F4UT,T03500,Matrix metalloproteinase-12 (MMP-12),https://idrblab.net/ttd/data/target/details/T03500,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
485,1966098,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,4301,AFDN,https://ctdbase.org/detail.go?type=gene&acc=4301,,,4301.0,AFDN,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of AFDN mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
486,1966099,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Asparanin A results in increased expression of CDH1 protein,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
487,1966100,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147.0,CHUK,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of CHUK mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
488,1966101,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1398,CRK,https://ctdbase.org/detail.go?type=gene&acc=1398,,,1398.0,CRK,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of CRK mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
489,1966102,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of CTNNB1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
490,1966103,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of CTNND1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
491,1966104,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Asparanin A results in increased expression of DDIT3 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
492,1966105,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,9732,DOCK4,https://ctdbase.org/detail.go?type=gene&acc=9732,,,9732.0,DOCK4,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of DOCK4 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
493,1966106,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),Asparanin A results in increased expression of DUSP1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
494,1966107,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,80824,DUSP16,https://ctdbase.org/detail.go?type=gene&acc=80824,,,80824.0,DUSP16,9606.0,Homo sapiens (human),Asparanin A results in increased expression of DUSP16 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
495,1966108,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2005,ELK4,https://ctdbase.org/detail.go?type=gene&acc=2005,,,2005.0,ELK4,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of ELK4 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
496,1966109,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,9606.0,Homo sapiens (human),Asparanin A results in increased expression of EPHA2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
497,1966110,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,55770,EXOC2,https://ctdbase.org/detail.go?type=gene&acc=55770,,,55770.0,EXOC2,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of EXOC2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
498,1966111,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,9855,FARP2,https://ctdbase.org/detail.go?type=gene&acc=9855,,,9855.0,FARP2,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of FARP2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
499,1966112,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of FAS mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
500,1966113,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2263,FGFR2,https://ctdbase.org/detail.go?type=gene&acc=2263,,,2263.0,FGFR2,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of FGFR2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
501,1966114,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2318,FLNC,https://ctdbase.org/detail.go?type=gene&acc=2318,,,2318.0,FLNC,9606.0,Homo sapiens (human),Asparanin A results in increased expression of FLNC mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
502,1966115,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,4303,FOXO4,https://ctdbase.org/detail.go?type=gene&acc=4303,,,4303.0,FOXO4,9606.0,Homo sapiens (human),Asparanin A results in increased expression of FOXO4 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
503,1966116,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),Asparanin A results in increased expression of GADD45A mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
504,1966117,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,9606.0,Homo sapiens (human),Asparanin A results in increased expression of GADD45B mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
505,1966118,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2770,GNAI1,https://ctdbase.org/detail.go?type=gene&acc=2770,,,2770.0,GNAI1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNAI1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
506,1966119,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2776,GNAQ,https://ctdbase.org/detail.go?type=gene&acc=2776,,,2776.0,GNAQ,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNAQ mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
507,1966120,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2784,GNB3,https://ctdbase.org/detail.go?type=gene&acc=2784,,,2784.0,GNB3,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNB3 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
508,1966121,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,59345,GNB4,https://ctdbase.org/detail.go?type=gene&acc=59345,,,59345.0,GNB4,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNB4 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
509,1966122,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,55970,GNG12,https://ctdbase.org/detail.go?type=gene&acc=55970,,,55970.0,GNG12,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNG12 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
510,1966123,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,54331,GNG2,https://ctdbase.org/detail.go?type=gene&acc=54331,,,54331.0,GNG2,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GNG2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
511,1966124,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of GRIN2B mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
512,1966125,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606.0,Homo sapiens (human),Asparanin A results in increased expression of HSPA1A mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
513,1966126,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606.0,Homo sapiens (human),Asparanin A results in increased expression of HSPB1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
514,1966127,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of IL1R1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
515,1966128,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3688,ITGB1,https://ctdbase.org/detail.go?type=gene&acc=3688,,,3688.0,ITGB1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of ITGB1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
516,1966129,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Asparanin A results in increased expression of JUN mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
517,1966130,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of KITLG mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
518,1966131,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of KRAS mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
519,1966132,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,1902,LPAR1,https://ctdbase.org/detail.go?type=gene&acc=1902,,,1902.0,LPAR1,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of LPAR1 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
520,1966133,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,9170,LPAR2,https://ctdbase.org/detail.go?type=gene&acc=9170,,,9170.0,LPAR2,9606.0,Homo sapiens (human),Asparanin A results in increased expression of LPAR2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
521,1966134,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,57121,LPAR5,https://ctdbase.org/detail.go?type=gene&acc=57121,,,57121.0,LPAR5,9606.0,Homo sapiens (human),Asparanin A results in increased expression of LPAR5 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
522,1966135,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAGI3 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
523,1966136,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,6416,MAP2K4,https://ctdbase.org/detail.go?type=gene&acc=6416,,,6416.0,MAP2K4,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAP2K4 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
524,1966137,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,5608,MAP2K6,https://ctdbase.org/detail.go?type=gene&acc=5608,,,5608.0,MAP2K6,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAP2K6 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
525,1966138,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,10746,MAP3K2,https://ctdbase.org/detail.go?type=gene&acc=10746,,,10746.0,MAP3K2,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAP3K2 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
526,1966139,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,51776,MAP3K20,https://ctdbase.org/detail.go?type=gene&acc=51776,,,51776.0,MAP3K20,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAP3K20 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
527,1966140,21575007,Comparative Toxicogenomics Database (CTD),Asparanin A,C540172,asparanin A,https://ctdbase.org/detail.go?type=chem&acc=C540172,6885,MAP3K7,https://ctdbase.org/detail.go?type=gene&acc=6885,,,6885.0,MAP3K7,9606.0,Homo sapiens (human),Asparanin A results in decreased expression of MAP3K7 mRNA,,,PMID:33561516,https://www.ncbi.nlm.nih.gov/pubmed/33561516,33561516,,
